Acreage (ACRDF) 10-Q 29 Jun 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information Document - shares	3 Months Ended
	Mar. 31, 2020	Jun. 25, 2020
Entity Information [Line Items]
Document Type	10-Q
Document Annual Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	000-56021
Entity Registrant Name	ACREAGE HOLDINGS, INC.
Entity Incorporation, State or Country Code	A1
Entity Tax Identification Number	98-1463868
Entity Address, Address Line One	366 Madison Avenue, 11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	646
Local Phone Number	600-9181
Title of 12(g) Security	Class A Subordinate Voting Shares, no par value
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		99,407,960
Entity Central Index Key	0001762359
Document Fiscal Year Focus	2020
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1
Amendment Flag	false

Statements of Financial Positio

Statements of Financial Position - USD ($)	3 Months Ended
	Mar. 31, 2020	Jun. 24, 2020	Dec. 31, 2019
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures		$ 50,000
Interest Receivable	$ 4,731,000		$ 5,774,000
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability	31,316
Debt Securities, Current	128
Cash and cash equivalents	13,944,000		26,505,000
Restricted cash	22,095,000		95,000
Inventory	21,057,000		18,083,000
Notes receivable, current	2,123,000		2,146,000
Other current assets	8,903,000		8,506,000
Total current assets	68,122,000		55,335,000
Long-term investments	4,725,000		4,499,000
Notes receivable, non-current	101,713,000		79,479,000
Capital assets, net	116,693,000		106,047,000
Operating lease right-of-use assets	55,411,000		51,950,000
Intangible assets, net	155,490,000		285,972,000
Goodwill	28,867,000		105,757,000
Other non-current assets	2,708,000		2,638,000
Total non-current assets	465,607,000		636,342,000
TOTAL ASSETS	533,729,000		691,677,000
Accounts payable and accrued liabilities	31,641,000		32,459,000
Taxes payable	7,469,000		4,740,000
Interest payable	366,000		291,000
Operating lease liability, current	3,253,000		2,759,000
Debt, current	22,514,000		15,300,000
Other current liabilities	2,524,000		1,604,000
Total current liabilities	67,767,000		57,153,000
Debt, non-current	47,467,000		28,186,000
Operating lease liability, non-current	51,016,000		47,522,000
Deferred tax liability	32,303,000		63,997,000
Other liabilities	5,000		25,000
Total non-current liabilities	130,791,000		139,730,000
TOTAL LIABILITIES	198,558,000		196,883,000
Common Stock, Value, Issued	0		0
Additional paid-in capital	671,738,000		615,678,000
Treasury stock, 842 SVS held in treasury	(21,054,000)		(21,054,000)
Accumulated deficit	(360,571,000)		(188,617,000)
Total Acreage Shareholders' equity	290,113,000		406,007,000
Non-controlling interests	45,058,000		88,787,000
TOTAL EQUITY	335,171,000		494,794,000
TOTAL LIABILITIES AND EQUITY	533,729,000		$ 691,677,000
Liabilities of Business Transferred under Contractual Arrangement, Current	$ 917,000	$ 3,000

Statements of Financial Posit_2

Statements of Financial Position Paranthetical - $ / shares shares in Thousands, $ / shares in Thousands	Dec. 31, 2019	Dec. 31, 2018
Treasury Stock, Common, Shares	842	842
Common Stock, No Par Value	$ 0	$ 0

Statements of Operations

Statements of Operations - USD ($) shares in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Allowance for Loan and Lease Losses, Write-offs	$ 8,161,000	$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	46,962	37,588
Profits interests vested to NCI units	1,000	625
Goodwill, Impairment Loss	$ 65,304,000	$ 0
Total revenues, net	24,225,000	12,897,000
Total cost of goods sold	(14,271,000)	(7,577,000)
Gross profit	9,954,000	5,320,000
General and administrative	13,032,000	10,158,000
Compensation expense	14,477,000	6,489,000
Equity-based compensation expense	34,737,000	18,977,000
Marketing	987,000	801,000
Asset Impairment Charges	187,775,000	0
Depreciation and amortization	2,067,000	908,000
Total operating expenses	261,236,000	37,333,000
Net operating loss	(251,282,000)	(32,013,000)
Income from investments, net	234,000	2,727,000
Interest income from loans receivable	1,647,000	730,000
Interest expense	(1,226,000)	(118,000)
Other (loss) income, net	(174,000)	92,000
Total other income	481,000	3,431,000
Loss before income taxes	(250,801,000)	(28,582,000)
Income tax benefit (expense)	28,572,000	(2,222,000)
Net loss	(222,229,000)	(30,804,000)
Less: net loss attributable to non-controlling interests	(50,275,000)	(7,427,000)
Net loss attributable to Acreage Holdings, Inc.	$ (171,954,000)	$ (23,377,000)
Net loss per share attributable to Acreage Holdings, Inc. - basic and diluted:	$ (1.85)	$ (0.29)
Weighted average shares outstanding - basic and diluted	92,902	79,440
Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities	$ 0	$ 0
Tangible Asset Impairment Charges	11,586,000
Retail [Member]
Total revenues, net	17,573,000	9,909,000
Total cost of goods sold	(10,889,000)	(5,881,000)
Wholesale [Member]
Total revenues, net	6,548,000	2,815,000
Total cost of goods sold	(3,382,000)	(1,696,000)
Other [Member]
Total revenues, net	$ 104,000	$ 173,000

Statements of Shareholders' Equ

Statements of Shareholders' Equity - USD ($)	Total	HSCP LLC Membership Units	Pubco Shares (as converted)	Share Capital	Treasury Stock	Accumulated Deficit	Shareholders' Equity	Noncontrolling Interest [Member]	Additional Paid-in Capital [Member]	Restricted Stock Units (RSUs) [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Dec. 31, 2018	$ 486,276,000			$ 414,757,000	$ (21,054,000)	$ (38,349,000)	$ 355,354,000	$ 130,922,000
Shares, Issued at Dec. 31, 2018		0	79,164,000
Redemption of membership units at RTO, shares			413,000
NCI adjustments for changes in ownership, shares		0	643,000
NCI adjustments for changes in ownership, value	0			3,640,000	0	0	3,640,000	(3,640,000)
Stock Issued During Period, Value, Acquisitions	7,948,000			3,948,000	0	0	3,948,000	4,000,000
Stock Issued During Period, Shares, Acquisitions		0	211,000
Other equity transactions	264,000			264,000	0	0	264,000	0
Stock Issued During Period, Shares, Other		0	12,000
Equity-based compensation expense and related issuances	16,187,000			16,187,000	0	0	16,187,000	0
Equity-based compensation shares		0	190,000
Net loss	(30,804,000)			0	0	(23,377,000)	(23,377,000)	(7,427,000)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Mar. 31, 2019	$ 479,871,000			438,796,000	(21,054,000)	(61,726,000)	356,016,000	123,855,000
Shares, Issued at Mar. 31, 2019		0	80,220,000
SVS secured for loan	12,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Dec. 31, 2019	$ 494,794,000			615,678,000	(21,054,000)	(188,617,000)	406,007,000	88,787,000
Shares, Issued at Dec. 31, 2019		0	90,646,000
Redemption of membership units at RTO, shares			6,671,000
NCI adjustments for changes in ownership, shares		0	113,000
NCI adjustments for changes in ownership, value	0			(6,564,000)	0	0	(6,564,000)	6,564,000
Proceeds from Noncontrolling Interests	(18,000)			0	0	0	0	(18,000)
Stock Issued During Period, Value, New Issues	27,887,000				0	0	27,887,000	0	$ 27,887,000
Stock Issued During Period, Shares, Acquisitions		0
Stock Issued During Period, Shares, New Issues			6,085,000
Other equity transactions	0
Equity-based compensation expense and related issuances	34,737,000			34,737,000	0	0	34,737,000	0
Equity-based compensation shares		0	586,000
Net loss	(222,229,000)			0	0	(171,954,000)	(171,954,000)	(50,275,000)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Mar. 31, 2020	$ 335,171,000			$ 671,738,000	$ (21,054,000)	$ (360,571,000)	$ 290,113,000	$ 45,058,000
Shares, Issued at Mar. 31, 2020		0	97,430,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value										$ 3.68

Statements of Cash Flows

Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (222,229)	$ (30,804)
Adjustments for:
Depreciation and amortization	2,067	908
Equity-settled expenses, including compensation	34,737	18,977
Asset Impairment Charges	187,775	0
Non-cash interest expense	319	0
Operating lease expense, non-cash	527	434
Deferred tax (income) expense	(31,694)	409
Non-cash income from investments, net	(234)	(2,182)
Change, net of acquisitions in:
Inventory	(2,374)	(1,694)
Other assets	(835)	(505)
Interest receivable	882	(1,153)
Accounts payable and accrued liabilities	(5,226)	559
Taxes payable	2,729	1,538
Interest payable	29	(248)
Other liabilities	(35)	131
Net cash used in operating activities	(25,401)	(13,630)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of capital assets	(7,790)	(8,288)
Investments in notes receivable	(11,560)	(8,629)
Collection of notes receivable	23	2,835
Proceeds from sale of capital assets	0	162
Business acquisitions, net of cash acquired	0	(20,770)
Purchases of intangible assets	0	(56,497)
Deferred acquisition costs and deposits	0	(300)
Distributions from investments	8	0
Proceeds from purchase of short-term investments	0	74,768
Net cash used in investing activities	(19,319)	(16,719)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Related Party Debt	5,000	0
Proceeds from (Repayments of) Related Party Debt	(20,000)	0
Sale Leaseback Transaction, Net Proceeds, Financing Activities	21,000	0
Payments of Financing Costs	(1,531)	0
Proceeds from issuance of private placement units, net	27,887	0
Collateral received	22,000	0
Settlement of taxes withheld	0	(2,790)
Repayment of debt	(197)	(7,621)
Net cash provided by (used in) financing activities	54,159	(10,411)
Net increase (decrease) in cash, cash equivalents and restricted cash	9,439	(40,760)
Cash, cash equivalents and restricted cash - Beginning of period	26,600	105,038	$ 105,038
Cash, cash equivalents and restricted cash - End of period	$ 36,039	$ 64,278	$ 26,600

Statements of Cash Flows Supple

Statements of Cash Flows Supplemental Disclosures - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid - non-lease	$ 2,000	$ 354,000
Income taxes paid	525,000	273,000
OTHER NON-CASH INVESTING AND FINANCING ACTIVITIES:
Capital assets not yet paid for	4,377,000	380,000
Issuance of Class D units for land	0	264,000
Convertible Debt	18,800,000	0
Liabilities of Business Transferred under Contractual Arrangement, Current	917,000	0
Capital assets not yet received	$ 0	$ 380,000

Nature of Operations

Nature of Operations	3 Months Ended
	Mar. 31, 2020
Nature of Operations [Abstract]
Nature of Operations [Text Block]	NATURE OF OPERATIONS Acreage Holdings, Inc. (the “Company”, “Pubco” or “Acreage”) was originally incorporated under the Business Corporations Act (Ontario) on July 12, 1989 as Applied Inventions Management Inc. On August 29, 2014, the Company changed its name to Applied Inventions Management Corp. The Company continued into British Columbia and changed its name to Acreage Holdings, Inc. on November 9, 2018. The Company’s Subordinate Voting Shares are listed on the Canadian Securities Exchange under the symbol “ACRG.U”, quoted on the OTCQX under the symbol “ACRGF” and traded on the Frankfurt Stock Exchange under the symbol “0VZ”. The Company owns, operates and has contractual relationships with cannabis cultivation facilities, dispensaries and other cannabis-related companies across the United States (“U.S.”). High Street Capital Partners, LLC, a Delaware limited liability company doing business as Acreage Holdings (“HSCP”), was formed on April 29, 2014. The Company became the indirect parent of HSCP on November 14, 2018 in connection with a reverse takeover (“RTO”) transaction described below. The Company’s corporate office and principal place of business is located at 366 Madison Avenue, 11th Floor, New York, New York in the U.S. The Company’s registered and records office address is Suite 2800, Park Place, 666 Burrard Street, Vancouver, British Columbia in Canada. The RTO transaction On September 21, 2018, the Company, HSCP, HSCP Merger Corp. (a wholly-owned subsidiary of the Company), Acreage Finco B.C. Ltd. (a special purpose corporation) (“Finco”), Acreage Holdings America, Inc. (“USCo”) and Acreage Holdings WC, Inc. (“USCo2”) entered into a combination agreement (the “Agreement”) whereby the parties agreed to combine their respective businesses, which would result in the RTO of Pubco by the security holders of HSCP, which was deemed to be the accounting acquiror. On November 14, 2018, the parties to the Agreement completed the RTO. The RTO transaction is described in detail in Note 1 to the Consolidated Financial Statements of the Company in the Company’s Annual Report on Form 10-K, filed with the SEC on May 29, 2020. Canopy Growth Corporation transaction On June 27, 2019, the Company and Canopy Growth Corporation (“Canopy Growth” or “CGC”) completed the transactions contemplated by the arrangement agreement dated April 18, 2019, as amended May 15, 2019, between Canopy Growth and Acreage. Canopy Growth was granted an option to acquire all outstanding shares of the Company, with a requirement to do so upon the occurrence of the occurrence of changes in U.S. federal law to permit the general cultivation, distribution, and possession of marijuana (the “Arrangement”). On June 24, 2020, Canopy Growth and the Company entered into an agreement to amend the terms of the Arrangement. Please refer to Note 13 for further discussion. COVID-19 In December 2019, a novel strain of coronavirus (“COVID-19”) emerged in Wuhan, China. Since then, it has spread to several other countries and infections have been reported around the world. On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic. In response to the outbreak, governmental authorities in the United States, Canada and internationally have introduced various recommendations and measures to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, quarantines, self-isolations, shelters-in-place and social distancing. The COVID-19 outbreak and the response of governmental authorities to try to limit it are having a significant impact on the private sector and individuals, including unprecedented business, employment and economic disruptions. The continued spread of COVID-19 in the United States, Canada and globally could have an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, as well as a deterioration of general economic conditions including a possible national or global recession. Shelter-in-place orders and social distancing practices designed to limit the spread of COVID-19 may affect our retail business. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Significant Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	SIGNIFICANT ACCOUNTING POLICIES Basis of presentation and going concern The Unaudited Condensed Consolidated Financial Statements of Acreage have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting only of normal recurring adjustments necessary for a fair presentation have been reflected in these Unaudited Condensed Consolidated Financial Statements. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2020. As reflected in the financial statements, the Company had an accumulated deficit as of March 31, 2020, as well as a net loss and net cash used in operating activities for the reporting period then ended. These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance of these financial statements. However, management believes that substantial doubt about the Company’s ability to meet our obligations for the next twelve months from the date these financial statements were issued has been alleviated due to, but not limited to, (i) capital raised between January and June 2020, (ii) access to future capital commitments (see Note 13), (iii) continued sales growth from our consolidated operations, (iv) latitude as to the timing and amount of certain operating expenses as well as capital expenditures, (v) restructuring plans that have already been put in place to improve the Company’s profitability and (vi) the Standby Equity Distribution Agreement described in Note 17 of the Unaudited Condensed Consolidated Financial Statements. If the Company is unable to raise additional capital whenever necessary, it may be forced to decelerate or curtail its footprint buildout or other operational activities until such time as additional capital becomes available. Such limitation of the Company’s activities would allow it to slow its rate of spending and extend its use of cash until additional capital is raised. However, management cannot provide any assurances that we will be successful in accomplishing any of our plans. Management also cannot provide any assurance as to unforeseen circumstances that could occur at any time within the next twelve months or thereafter which could increase our need to raise additional capital on an immediate basis. Use of estimates The preparation of the Company’s Unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts that are reported in the Unaudited Condensed Consolidated Financial Statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates inherent in the preparation of the accompanying Unaudited Condensed Consolidated Financial Statements include the fair value of assets acquired and liabilities assumed in business combinations, assumptions relating to equity-based compensation expense, estimated useful lives for property, plant and equipment and intangible assets, the valuation allowance against deferred tax assets and the assessment of potential impairment charges on goodwill, intangible assets and investments in equity and notes receivable. These interim Unaudited Condensed Consolidated Financial Statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 as filed with the Securities and Exchange Commission on May 29, 2020 (the “2019 Form 10-K”). Emerging growth company We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. Functional and presentation currency The Unaudited Condensed Consolidated Financial Statements and the accompanying notes are expressed in U.S. dollars. Financial metrics are presented in thousands. Other metrics, such as shares outstanding, are presented in thousands unless otherwise noted. Basis of consolidation Our Unaudited Condensed Consolidated Financial Statements include the accounts of Acreage, its subsidiaries and variable interest entities (“VIEs”) where we are considered the primary beneficiary, if any, after elimination of intercompany accounts and transactions. Investments in entities in which the Company has significant influence, but less than a controlling financial interest, are accounted for using the equity method. Our proportionate share of net income or loss of the entity is recorded in Income (loss) from investments, net in the Consolidated Statements of Operations. The unaudited and audited consolidated financial statements are referred to as the “Financial Statements” herein. The unaudited condensed consolidated statements of operations are referred to as the “Statements of Operations” herein. The unaudited and audited condensed consolidated statements of financial position are referred to as the “Statements of Financial Position” herein. The unaudited condensed consolidated statements of cash flows are referred to as the “Statements of Cash Flows” herein. Restricted cash Restricted cash represents funds contractually held for specific purposes and, as such, not available for general corporate purposes. Cash and restricted cash, as presented on the Statements of Cash Flows, consists of $13,944 and $22,095 as of March 31, 2020 , respectively, and $26,505 and $95 as of December 31, 2019 . Impairment of long-lived assets Goodwill and indefinite-lived intangible assets are not subject to amortization and are tested for impairment annually or more frequently if events or changes in circumstances indicate that they might be impaired. Goodwill and indefinite-lived intangible assets are tested at the individual business level. The Company may first assess qualitative factors and, if it determines it is more likely than not that the fair value is less than the carrying value, then proceed to a quantitative test if necessary. Finite-lived intangible assets and other long-lived assets are tested for impairment based on undiscounted cash flows when events or changes in circumstances indicate that the carrying amount may not be recoverable. Accounting for warrants The Company determines the accounting classification of warrants it issues, as either liability or equity classified, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity , then in accordance with ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock . Under ASC 480, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the Company to settle the warrants or the underlying shares by paying cash or other assets, or warrants that must or may require settlement by issuing a variable number of shares. If warrants do not meet the liability classification under ASC 480-10, the Company assesses the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815-40, and in order to conclude equity classification, the Company also assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP. After all relevant assessments, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statements of operations. Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date. Net loss per share Net loss per share represents the net loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis. Basic and diluted loss per share are the same as of March 31, 2020 and 2019 as the issuance of shares upon conversion, exercise or vesting of outstanding units would be anti-dilutive in each period. There were 46,962 and 37,588 anti-dilutive shares outstanding as of March 31, 2020 and 2019 , respectively. Refer to Note 16 for further details. Accounting Pronouncements Recently Adopted As of December 2019, the Company early adopted ASU 2017-04 - Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). The objective of ASU 2017-04 is to simplify how an entity is required to test goodwill for impairment. Under previous GAAP, entities were required to test goodwill for impairment using a two-step approach. Under the amendments in ASU 2017-04, an entity performs its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The adoption of ASU 2017-04 did not have an effect on the Company’s Financial Statements. Accounting Pronouncements Not Yet Adopted In June 2016, the FASB issued ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which was subsequently revised by ASU 2018-19. The ASU introduces a new model for assessing impairment on most financial assets. Entities will be required to use a forward-looking expected loss model, which will replace the current incurred loss model, which will result in earlier recognition of allowance for losses. The ASU will be effective for the Company’s first interim period of fiscal 2023, and the Company is currently evaluating the impact of the new standard.

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2020
Acquisitions [Abstract]
Business Combination Disclosure [Text Block]	ACQUISITIONS During the three months ended March 31, 2020 , the Company did not complete any business combinations. During the three months ended March 31, 2019 , the Company completed the following business combinations, and has allocated each purchase price as follows: Purchase Price Allocation Thames Valley (1) NCC (2) Total Assets acquired: Cash and cash equivalents $ 106 $ 696 $ 802 Inventory 39 170 209 Other current assets 1 36 37 Capital assets, net — 539 539 Goodwill 3,596 4,192 7,788 Intangible assets - cannabis licenses 14,850 2,500 17,350 Other non-current assets — 25 25 Liabilities assumed: Accounts payable and accrued liabilities (121 ) (24 ) (145 ) Other current liabilities — (621 ) (621 ) Deferred tax liability (3,399 ) (461 ) (3,860 ) Other liabilities — (175 ) (175 ) Fair value of net assets acquired $ 15,072 $ 6,877 $ 21,949 Consideration paid: Cash 15,072 — 15,072 Deferred acquisition costs and deposits — 100 100 Subordinate Voting Shares — 3,948 3,948 Settlement of pre-existing relationship — 830 830 Fair value of previously held interest — 1,999 1,999 Total consideration $ 15,072 $ 6,877 $ 21,949 Subordinate Voting Shares issued — 211 211 The operating results of the above acquisitions were not material to the periods presented. (1) On January 29, 2019, the Company acquired 100% of Thames Valley Apothecary, LLC (“Thames Valley”), a dispensary license holder in Connecticut. (2) On March 4, 2019, the Company acquired the remaining 70% ownership interest in NCC LLC (“NCC”), a dispensary license holder in Illinois. The market price used in valuing SVS issued was $18.70 . As a result of this acquisition, the previously held interest in NCC was re-measured, resulting in a gain of $999 , which was recorded in Income from investments, net in the Statements of Operations during the three months ended March 31, 2019 . Deferred acquisition costs and deposits The Company makes advance payments to certain acquisition targets for which the transfer is pending certain regulatory approvals prior to the acquisition date. As of March 31, 2020 and December 31, 2019

Intangible Assets and Goodwill

Intangible Assets and Goodwill	3 Months Ended
	Mar. 31, 2020
Intangibles and Goodwill [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	INTANGIBLE ASSETS AND GOODWILL Intangible assets The following table details our intangible asset balances by major asset classes: Intangibles March 31, 2020 December 31, 2019 Finite-lived intangible assets: Management contracts $ 19,580 $ 52,438 Customer relationships — 4,600 Developed technology — 3,100 19,580 60,138 Accumulated amortization on finite-lived intangible assets: Management contracts (3,639 ) (5,750 ) Customer relationships — (649 ) Developed technology — (114 ) (3,639 ) (6,513 ) Finite-lived intangible assets, net 15,941 53,625 Indefinite-lived intangible assets Cannabis licenses 139,549 232,347 Total intangibles, net $ 155,490 $ 285,972 The average useful life of finite-lived intangible assets ranges from six to nine years . Impairment of intangible assets In December 2019, a novel strain of coronavirus emerged in Wuhan, China, which since then, has spread worldwide. As a result of the recent global economic impact and uncertainty due to the COVID-19 pandemic, the Company concluded a triggering event had occurred as of March 31, 2020 , and accordingly, performed interim impairment testing. The Company performed a quantitative analysis and concluded certain of the indefinite-lived cannabis licenses had a fair value below the carrying value as of March 31, 2020 . During the three months ended March 31, 2020 and 2019, the Company recognized impairment charges of $92,798 and nil , respectively, with respect to its indefinite-lived intangible assets at Acreage Florida, Inc., Form Factory Holdings, LLC and Kanna, Inc. The charge is recognized in Loss on impairment on the Statements of Operations. The Company evaluated the recoverability of the related finite-lived intangible assets to be held and used by comparing the carrying amount of the assets to the future net undiscounted cash flows expected to be generated by the assets, or comparable market sales data to determine if the carrying value is recoverable. During the three months ended March 31, 2020 and 2019, the Company recognized impairment charges of $8,324 and nil , respectively, with respect to its finite-lived intangible assets at Form Factory and CWG Botanicals, Inc. The charge is recognized in Loss on impairment on the Statements of Operations. These impairments resulted in the recognition of a tax provision benefit and an associated reversal of deferred tax liabilities of $31,316 for the three months ended March 31, 2020 . During the second quarter of fiscal 2020, the Company determined certain indefinite-lived intangible assets met the held-for-sale criteria which includes: management commits to a plan to sell; the asset is available for immediate sale; an active program to locate a buyer exists; the sale of the asset is probable and expected to be completed within one year; the asset is being actively marketed for sale; and it is unlikely that significant changes to the plan will be made. The Company has identified these assets relating to cannabis licenses within the Company’s national footprint and has evaluated the assets as part of interim impairment testing as noted above. The Company is in the process of evaluating whether this meets the criteria for discontinued operations. WCM Refinancing On March 6, 2020, the Company closed on a refinancing, transaction and conversion related to Northeast Patients Group, operating as Wellness Connection of Maine (“WCM”), a medical cannabis business in Maine, resulting in ownership of WCM by three individuals. In connection with the transaction, WCM converted from a non-profit corporation to a for-profit corporation. Refer to Note 6 for further details. Concurrently, a portion of the management contract was converted into a promissory note of $18,800 in Notes receivable, non-current on the Statements of Financial Position in exchange for the previously held management contract. An impairment was determined as the differential between the net carrying value of the previously held management contract and the promissory note received in exchange. This resulted in an impairment loss to finite-lived intangible assets of $9,395 in Loss on impairment on the Statements of Operations. Amortization expense recorded during the three months ended March 31, 2020 and 2019 was $1,165 and $661 , respectively. Expected annual amortization expense for existing intangible assets subject to amortization at March 31, 2020 is as follows for each of the next five fiscal years: Amortization of Intangibles 2020 2021 2022 2023 2024 Amortization expense $ 1,623 $ 2,164 $ 2,164 $ 2,164 $ 2,164 Goodwill The following table details the changes in the carrying amount of goodwill: Goodwill Total December 31, 2019 $ 105,757 Acquisitions — Impairment (76,890 ) March 31, 2020 $ 28,867 Also as a result of the recent global economic impact and uncertainty due to the COVID-19 pandemic, the Company concluded a triggering event had occurred as of March 31, 2020 , and accordingly, performed interim impairment testing. During the three months ended March 31, 2020 and 2019, the Company recognized impairment charges of $65,304 and nil , respectively, with respect to its goodwill related to Form Factory. The Company applied the DCF approach to determine the fair value of Form Factory. The charge is recognized in Loss on impairment on the Statements of Operations. Pursuant to the WCM refinancing described above, the Company recognized an impairment loss to goodwill of $11,586 on Loss of impairment

Investments

Investments	3 Months Ended
	Mar. 31, 2020
Investments [Abstract]
Investment Holdings, Schedule of Investments [Text Block]	INVESTMENTS The carrying values of the Company’s investments in the Statements of Financial Position as of March 31, 2020 and December 31, 2019 are as follows: Investments March 31, 2020 December 31, 2019 Investments held at FV-NI 4,607 4,376 Equity method investments 118 123 Total long-term investments $ 4,725 $ 4,499 Income from investments, net in the Statements of Operations during the three months ended March 31, 2020 and 2019 is as follows: Investment income Three Months Ended March 31, 2020 2019 Short-term investments $ — $ 500 Investments held at FV-NI 240 1,203 Equity method investments (6 ) 1,024 Income from investments, net $ 234 $ 2,727 Short-term investments The Company from time to time invests in U.S. Treasury bills which are classified as held-to-maturity and measured at amortized cost. These range in original maturity from three to six months, and bear interest ranging from 2.2% - 2.4% . During the three months ended March 31, 2019 , short-term investments in U.S. Treasury bills in the amount of $74,768 matured. Investments held at FV-NI The Company has investments in equity of several companies that do not result in significant influence or control. These investments are carried at fair value, with gains and losses recognized in the Statements of Operations. Equity method investments The Company accounts for investments in which it can exert significant influence but does not control as equity method investments. As of March 31, 2020 and December 31, 2019

Capital Assets, net

Capital Assets, net	3 Months Ended
	Mar. 31, 2020
Capital Assets, net [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	CAPITAL ASSETS, net Net property and equipment consisted of: March 31, 2020 December 31, 2019 Land $ 11,611 $ 9,839 Building 37,516 34,522 Right-of-use asset, finance leases 5,980 5,954 Construction in progress 17,125 17,288 Furniture, fixtures and equipment 27,897 21,019 Leasehold improvements 23,240 22,682 Capital assets, gross $ 123,369 $ 111,304 Less: accumulated depreciation (6,676 ) (5,257 ) Capital assets, net $ 116,693 $ 106,047 Depreciation of capital assets for the three months ended March 31, 2020 and 2019 include $902 and $247 of depreciation expense, and $600 and $410 , that was capitalized to inventory, respectively.

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases of Lessee Disclosure [Text Block]	LEASES The Company leases land, buildings, equipment and other capital assets which it plans to use for corporate purposes and the production and sale of cannabis products. Leases with an initial term of 12 months or less are not recorded on the Statements of Financial Position and are expensed in the Statements of Operations on the straight-line basis over the lease term. The Company does not have any material variable lease payments, and accounts for non-lease components separately from leases. Balance Sheet Information Classification March 31, 2020 December 31, 2019 Right-of-use assets Operating Operating lease right-of-use assets $ 55,411 $ 51,950 Finance Capital assets, net 5,764 5,832 Total right-of-use assets $ 61,175 $ 57,782 Lease liabilities Current Operating Operating lease liability, current $ 3,253 $ 2,759 Financing Debt, current 74 49 Non-current Operating Operating lease liability, non-current 51,016 47,522 Financing Debt, non-current 5,932 6,083 Total lease liabilities $ 60,275 $ 56,413 Statement of Operations Information Classification Three Months Ended Three Months Ended March 31, 2019 Short-term lease expense General and administrative $ 317 $ 298 Operating lease expense General and administrative 2,020 956 Finance lease expense: Amortization of right of use asset Depreciation and amortization 95 2 Interest expense on lease liabilities Interest expense 215 12 Sublease income Other (loss) income, net (16 ) (43 ) Net lease cost $ 2,314 $ 927 Statement of Cash Flows Information Classification Three Months Ended Three Months Ended March 31, 2019 Cash paid for operating leases Net cash used in operating activities 1,493 522 Cash paid for finance leases - interest Net cash used in operating activities 196 12 The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of March 31, 2020 : Maturity of lease liabilities Operating Leases Finance Leases 2020 $ 6,414 $ 652 2021 8,629 873 2022 8,484 893 2023 8,310 914 2024 8,030 936 Thereafter 53,986 18,740 Total lease payments $ 93,853 $ 23,008 Less: imputed interest 39,584 17,002 Present value of lease liabilities $ 54,269 $ 6,006 Weighted average remaining lease term (years) 12 24 Weighted average discount rate 10% 14% As of March 31, 2020

Inventory

Inventory	3 Months Ended
	Mar. 31, 2020
Inventory [Abstract]
Inventory Disclosure [Text Block]	INVENTORY March 31, 2020 December 31, 2019 Retail inventory $ 2,103 $ 1,784 Wholesale inventory 13,816 11,993 Cultivation inventory 3,235 3,021 Supplies & other 1,903 1,285 Total $ 21,057 $ 18,083

Debt

Debt	3 Months Ended
	Mar. 31, 2020
Debt [Abstract]
Debt Disclosure [Text Block]	DEBT The Company’s debt balances consist of the following: Debt balances March 31, 2020 December 31, 2019 NCCRE loan $ 487 $ 492 Seller’s notes 2,744 2,810 Related party debt — 15,000 Financing liability 19,052 19,052 Finance lease liabilities 6,006 6,132 SAF loan 19,438 — SAF loan collateral (related party) 22,254 — Total debt $ 69,981 $ 43,486 Less: current portion of debt 22,514 15,300 Total long-term debt $ 47,467 $ 28,186 The interest expense related to the Company’s debt during the three months ended March 31, 2020 and 2019 consists of the following: Interest Expense Three Months Ended March 31, 2020 2019 NCCRE loan 5 5 Seller’s notes 72 101 Interest expense on financing liability 591 — Interest expense on finance lease liability 215 12 Interest expense on SAF loan 89 — Interest expense on SAF loan collateral (related party) 254 — Total interest expense $ 1,226 $ 118 NCC Real Estate, LLC (“NCCRE”) loan NCCRE, which is owned by the Company’s consolidated subsidiary HSC Solutions, LLC, entered into a $550 secured loan with a financial institution for the purchase of a building in Rolling Meadows, Illinois in December 2016. The building is leased to NCC. The promissory note payable carries a fixed interest rate of 3.7% and is due in December 2021. Seller’s notes The Company issued Seller’s notes payable in connection with several transactions, bearing interest at rates ranging from 3.5% to 10% . Related party debt During the year ended December 31, 2019, the Company’s CEO made a non-interest bearing loan of $15,000 to Acreage. In January 2020, he made an additional loan of $5,000 to Acreage. These amounts were subsequently repaid in March 2020. Financing liability In connection with the Company’s failed sale-leaseback transaction (refer to Note 14), a financing liability was recognized equal to the cash proceeds received. The Company will recognize the cash payments made on the lease as interest expense, and the principal will be derecognized upon expiration of the lease. SAF loan and collateral On March 11, 2020, the Company borrowed $21,000 from an institutional lender pursuant to a credit facility. The credit facility permits the Company to borrow up to $100,000 , which may be drawn down by the Company in four tranches, maturing two years from the date of the first draw down. The Company will pay an annual interest rate of 3.55% on the first advance of debt for a term of two years. The borrowed amounts under the credit facility are fully collateralized by $22,000 of restricted cash, which was borrowed pursuant to the loan transaction described below. Any additional draws must be fully cash collateralized as well. Also on March 11, 2020, the Company closed $22,000 in borrowings pursuant to a loan transaction with IP Investment Company, LLC (the “Lender”). The maturity date is 366 days from the closing date of the loan transaction. The Company will pay monthly interest on the collateral in the form of 41 SVS through the maturity date. The Lender may put any unsold interest shares to the Company upon maturity at a price of $4.50 per share. Kevin Murphy, the Company’s Chief Executive Officer, loaned $21,000 of the $22,000 borrowed by the Company to the Lender. The loan is secured by the non-U.S. intellectual property assets, a cannabis state license and 12,000 SVS shares of the Company. The Company has determined such interest on collateral to be a mandatorily redeemable financial instrument that is recorded as a liability in accordance with ASC 480 - Distinguishing liabilities from equity (“ASC 480”). The liability is calculated based upon the share interest multiplied by the maturity price of $4.50 per share. The liability amounted to $128 as of March 31, 2020 and was recorded in Debt, current

Shareholders' Equity and Non-Co

Shareholders' Equity and Non-Controlling Interests	3 Months Ended
	Mar. 31, 2020
Shareholders' Equity and Non-Controlling Interests [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS The table below details the change in Pubco shares outstanding by class for the three months ended March 31, 2020 : Shareholders’ Equity Subordinate Voting Shares Subordinate Voting Shares Held in Treasury Proportionate Voting Shares (as converted) Multiple Voting Shares Total Shares Outstanding December 31, 2019 68,177 (842 ) 23,143 168 90,646 Issuances 6,671 — — — 6,671 NCI conversions 113 — — — 113 PVS conversions 294 — (294 ) — — March 31, 2020 75,255 (842 ) 22,849 168 97,430 The table below details the change in Pubco shares outstanding by class for the three months ended March 31, 2019 : Shareholders’ Equity Subordinate Voting Shares Subordinate Voting Shares Held in Treasury Proportionate Voting Shares (as converted) Multiple Voting Shares Total Shares Outstanding December 31, 2018 21,943 (842 ) 57,895 168 79,164 Issuances 413 — — — 413 NCI conversions 643 — — — 643 PVS conversions 21,472 — (21,472 ) — — March 31, 2019 44,471 (842 ) 36,423 168 80,220 Warrants A summary of the warrants activity outstanding is as follows: Warrants Three Months Ended March 31, 2020 2019 Beginning balance 2,040 2,259 Granted 6,085 — Expired — — Ending balance 8,125 2,259 On February 10, 2020, the Company raised $27,887 , net of issuance costs, from a private placement of 6,085 warrants priced at $4.93 per unit. The warrants were automatically exercised on March 2, 2020 for no additional consideration, and each unit sold consists of one SVS voting share and one purchase warrant with an exercise price of $5.80 and a five-year expiration. The Company evaluated the warrants for liability or equity classification in accordance with ASC 480 and determined that equity treatment was appropriate as the warrants only require settlement through the issuance of the Company’s SVS which are not redeemable, and do not represent an obligation to issue a variable number of shares. Accordingly, the warrants were classified as equity and are not subject to remeasurement at each balance sheet date. The exercise price of all other warrants outstanding as of March 31, 2020 is $25 per share. The weighted-average remaining contractual life of the warrants outstanding is approximately 4 years . There was no aggregate intrinsic value for warrants outstanding as of March 31, 2020 . Non-controlling interests - convertible units The Company has NCIs in consolidated subsidiaries USCo2 and HSCP. The non-voting shares of USCo2 and HSCP units make up substantially all of the NCI balance as of March 31, 2020 and are convertible for either one Subordinate Voting Share of Pubco or cash, as determined by the Company. Summarized financial information of HSCP is presented below. USCo2 does not have discrete financial information separate from HSCP. HSCP net asset reconciliation March 31, 2020 December 31, 2019 Current assets $ 68,038 $ 55,296 Non-current assets 452,280 584,812 Current liabilities (59,525 ) (46,434 ) Non-current liabilities (91,035 ) (75,219 ) Other NCI balances (491 ) (1,041 ) Accumulated equity-settled expenses (148,310 ) (111,934 ) Net assets $ 220,957 $ 405,480 HSCP/USCo2 ownership % of HSCP 20.17 % 21.64 % Net assets allocated to USCo2/HSCP $ 44,567 $ 87,746 Net assets attributable to other NCIs 491 1,041 Total NCI $ 45,058 $ 88,787 Three Months Ended March 31, HSCP Summarized Statement of Operations 2020 2019 Net loss allocable to HSCP/USCo2 $ (235,203 ) $ (28,958 ) HSCP/USCo2 weighted average ownership % of HSCP 21.15 % 25.63 % Net loss allocated to HSCP/USCo2 $ (49,745 ) $ (7,422 ) Net loss allocated to other NCIs (530 ) (5 ) Net loss attributable to NCIs $ (50,275 ) $ (7,427 ) As of March 31, 2020 , USCo2’s non-voting shares owned approximately 0.61% of HSCP units. USCo2’s capital structure is comprised of voting shares (approximately 69% ), all of which are held by the Company, and of non-voting shares (approximately 31% ) held by certain former HSCP members. Certain executive employees and profits interests holders own approximately 19.56% of HSCP units. The remaining 79.83% interest in HSCP is held by USCo and represents the members’ equity attributable to shareholders of the parent. During the three months ended March 31, 2020 and 2019, the Company had several transactions with HSCP and USCo2 that changed its ownership interest in the subsidiaries but did not result in loss of control. These transactions included business acquisitions and intangible purchases where equity was issued as consideration (see Notes 3 and 4) and the redemption of HSCP and USCo2 convertible units for Pubco shares (as shown in the table below), and resulted in a $6,564 and $(3,640) allocation from NCI to shareholders' equity for the three months ended March 31, 2020 and 2019, respectively. A reconciliation of the beginning and ending amounts of convertible units is as follows: Three Months Ended March 31, Convertible Units 2020 2019 Beginning balance 25,035 27,340 Issuance of NCI units — 198 Vested LLC C-1s canceled (1,310 ) (123 ) LLC C-1s vested 1,000 625 NCI units settled in cash — (643 ) NCI units converted to Pubco (113 ) — Ending balance 24,612 27,397

Equity-Based Compensation

Equity-Based Compensation	3 Months Ended
	Mar. 31, 2020
Equity-based compensation [Abstract]
Share-based Payment Arrangement [Text Block]	EQUITY-BASED COMPENSATION EXPENSE Equity-based compensation expense recognized in the Statements of Operations for the periods presented is as follows: Equity-based compensation expense Three Months Ended March 31, 2020 2019 Equity-based compensation - Plan $ 19,290 $ 18,881 Equity-based compensation - other 15,447 96 Total equity-based compensation expense $ 34,737 $ 18,977 Equity-based compensation - Plan (Acreage Holdings, Inc. Omnibus Incentive Plan) In connection with the RTO transaction, the Company’s Board of Directors adopted an Omnibus Incentive Plan, as amended May 7, 2019 and June 19, 2019 (the “Plan”), which permits the issuance of stock options, stock appreciation rights, stock awards, share units, performance shares, performance units and other stock-based awards up to an amount equal to 15% of the issued and outstanding Subordinate Voting Shares of the Company. Restricted Share Units (“RSUs”) Three Months Ended Restricted Share Units (Fair value information expressed in whole dollars) RSUs Weighted Average Grant Date Fair Value Unvested, beginning of period 7,843 $ 15.10 Granted (1) 4,155 3.68 Forfeited (1,593 ) 14.48 Vested (1,247 ) 8.00 Unvested, end of period 9,158 $ 10.99 RSUs of the Company generally vest over a period of two years . The fair value for RSUs is based on the Company’s share price on the date of the grant. The Company recorded $13,414 as compensation expense during the three months ended March 31, 2020 . The fair value of RSUs vested during the three months ended March 31, 2020 was $3,503 . The total weighted average remaining contractual life and aggregate intrinsic value of unvested RSUs at March 31, 2020 was approximately 2 years and $21,247 , respectively. Unrecognized compensation expense related to these awards at March 31, 2020 was $77,083 and is expected to be recognized over a weighted average period of approximately 2 years . There were 744 and 4 vested RSUs that are pending delivery or deferred as of March 31, 2020 and 2019, respectively. On February 20, 2020, the Company issued 1,505 RSUs to certain executives with a weighted-average grant fair value of $5.11 per share. 148 of the 1,505 RSUs vested immediately. Certain shares are subject to restriction thus a discount for lack of marketability was applied that correlates to the period of time. On March 13, 2020, the Company issued 630 RSUs to employees of the Company. All of these units vested immediately, with a fair market value of $2.15 , which was the closing price of the Company’s subordinate voting shares on March 13, 2020. The entire amount is pending delivery as of March 31, 2020 . (1) Equity-based compensation - Plan (CGC Awards) Included in the RSUs granted during the three months ended March 31, 2020 are “CGC Awards” issued in connection with the RSUs which were granted in July 2019: On June 27, 2019, pursuant to the Arrangement Agreement (as defined in Note 13), 4,909 RSUs were awarded in total to five executive employees under the Plan. These awards vest as follows: 25% in June 2020, 25% in June 2021 and 50% three months following the Acquisition (as defined in Note 13) . The Company recorded $2,762 as compensation expense during the three March 31, 2020 in connection with these awards. A discount for lack of marketability was applied that correlates to the period of time certain of these shares are subject to restriction. On July 31, 2019, the Company issued 1,778 RSUs to employees with unvested RSUs and stock options ("make-whole awards") as at the date of the Option Premium payment (as defined in Note 13). The RSUs were issued to provide additional incentive for employees that were not eligible to receive the full Option Premium and were subject to the same vesting terms as the unvested options and RSUs held as of the grant date. The Company recorded $2,049 as compensation expense during the three months ended March 31, 2020 in connection with these awards. Stock options Three Months Ended Stock Options (Exercise price expressed in whole dollars) Options Weighted Average Exercise Price Options outstanding, beginning of period 5,607 $ 21.56 Granted 191 5.75 Forfeited (731 ) 16.39 Exercised — — Options outstanding, end of period 5,067 $ 21.71 Options exercisable, end of period 1,718 $ 24.80 Stock options of the Company generally vest over a period of three years and have an expiration period of 10 years . The weighted average contractual life remaining for options outstanding and exercisable as of March 31, 2020 was approximately 9 years . The Company recorded $5,876 as compensation expense during the three months ended March 31, 2020 , in connection with these awards. As of March 31, 2020 , unamortized expense related to stock options totaled $41,088 and is expected to be recognized over a weighted-average period of approximately 2 years . There was no aggregate intrinsic value for options outstanding or exercisable as of March 31, 2020 . Equity-based compensation - other HSCP C-1 Profits Interests Units (“Profits Interests”) These membership units qualify as profits interests for U.S. federal income tax purposes and were accounted for in accordance with ASC 718, Compensation - Stock Compensation. HSCP amortizes awards over service period and until awards are fully vested. The following table summarizes the status of unvested Profits Interests for the three months ended March 31, 2020 : Three Months Ended Profits Interests (Fair value information expressed in whole dollars) Number of Units Weighted Average Grant Date Fair Value Unvested, beginning of period 1,000 $ 0.43 Class C-1 units granted — — Class C-1 units canceled — — Class C-1 vested (1,000 ) 0.43 Unvested, end of period — $ — The Company recorded $70 as compensation expense in connection with these awards during the three months ended March 31, 2020 . The fair value of Profits Interests vested during the three months ended March 31, 2020 was $1,239 . As of March 31, 2020, all Profits Interests were fully vested. Restricted Shares (“RSs”) In connection with the Company’s acquisition of Form Factory during 2019 , 1,369 restricted shares with a grant date fair value of $20.45 were issued to former employees of Form Factory subject to future service conditions, which fully vest 24 months from the acquisition date. The fair value for RSs is based on the Company’s share price on the date of the grant. The Company recorded compensation expense of $15,377 during the three months ended March 31, 2020 in connection with these awards. During the three months ended March 31, 2020 , certain employees separated from the Company, resulting in 1,128 RSs accelerating vesting and $14,888 incurred in expenses. The total weighted average remaining contractual life and aggregate intrinsic value of RSs at March 31, 2020 was approximately 1 year and $559 , respectively. As of March 31, 2020 , unamortized expense related to RSs totaled $1,991 and is expected to be recognized over a weighted average period of approximately 1 year . There was no comparable RS activity during the three months ended March 31, 2019

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	COMMITMENTS and CONTINGENCIES Commitments The Company provides revolving lines of credit to several of its portfolio companies. Refer to Note 6 for further information. Definitive agreements On April 17, 2019, the Company entered into a definitive agreement to acquire Deep Roots Medical, LLC (“Deep Roots”), a vertically integrated license holder in Nevada, for consideration of 4,762 HSCP units (valued at approximately $11,048 based on the March 31, 2020 closing price of $2.32 per share) and $20,000 in cash. The Company announced the termination of the agreement by Deep Roots on April 3, 2020 following March 31, 2020, the end date for consummating the transaction. During the year ended December 31, 2018, the Company entered into a definitive agreement to acquire all ownership interests in GCCC Management, LLC, a management company overseeing the operations of Greenleaf Compassionate Care Center, Inc., a non-profit cultivation and processing facility in Rhode Island, for cash consideration of $10,000 . The agreement terminated in April 2020. Canopy Growth On June 19, 2019, the shareholders of the Company and of Canopy Growth separately approved the proposed arrangement involving the two companies (the “Existing Arrangement”), and on June 21, 2019, the Supreme Court of British Columbia granted a final order approving the Existing Arrangement. Effective June 27, 2019, the articles of the Company were amended pursuant to a plan of arrangement to provide that, upon a change in federal laws in the United States to permit the general cultivation, distribution and possession of marijuana (as defined in the relevant legislation) or to remove the regulation of such activities from the federal laws of the United States (the “Triggering Event”), subject to the satisfaction of the conditions set out in the arrangement agreement entered into between Acreage and Canopy Growth on April 18, 2019, as amended on May 15, 2019 (the “Arrangement Agreement”), Canopy Growth will acquire all of the issued and outstanding shares in the capital of the Company (each, an “Acreage Share”). Under the terms of the Arrangement Agreement, holders of Acreage Shares and certain securities convertible or exchangeable into Class A subordinate voting shares of Acreage (the “Subordinate Voting Shares”) as of the close of business on June 26, 2019 , received approximately $2.63 , being their pro rata portion (on an as converted to Subordinate Voting Share basis) of $300,000 (the “Option Premium”) paid by Canopy Growth. Upon the occurrence of the Triggering Event and subject to the satisfaction or waiver of the conditions to closing set out in the Arrangement Agreement, Canopy Growth will acquire (the “Acquisition”) each of the Subordinate Voting Shares of Acreage (following the automatic conversion of the Class B proportionate voting shares and Class C multiple voting shares of Acreage into Subordinate Voting Shares) for the payment of 0.5818 of a common share of Canopy Growth (each whole common share, a “Canopy Growth Share”) per Subordinate Voting Share (subject to adjustment in accordance with the terms of the Arrangement Agreement) (the “Exchange Ratio”). HSCP unit holders will be required to convert their units within three years following the closing of the Acquisition as will holders of non-voting shares of USCo2. Pursuant to the terms of the Arrangement Agreement, the Company is permitted to issue up to an additional 58,000 Subordinate Voting Shares (of which approximately 39,000 remain available for issuance as of March 31, 2020 ) without any adjustment being required to the Exchange Ratio. The Exchange Ratio is subject to adjustment in the circumstances set out in the Arrangement Agreement. Proposed Amendment to Canopy Growth Arrangement On June 24, 2020, Acreage and Canopy Growth entered into a proposal agreement (the “Proposal Agreement”) which sets out, among other things, the terms and conditions upon which the parties are proposing to amend the Arrangement Agreement (the “Amended Arrangement Agreement”) and amend and restate the existing plan of arrangement (the “Amended Plan of Arrangement”). The effectiveness of the Amended Arrangement Agreement and the implementation of the Amended Plan of Arrangement is subject to the conditions set out in the Proposal Agreement, including, among others, approval by (i) the Supreme Court of British Columbia at a hearing upon the procedural and substantive fairness of the terms and conditions of the Amended Plan of Arrangement (“Court Approval”); and (ii) the shareholders of Acreage as required by applicable corporate and securities laws. Upon receipt of Acreage shareholder approval, Court Approval and the satisfaction of all other conditions set out in the Proposal Agreement, including the advance of $50,000 to a subsidiary of Acreage pursuant to a loan, Acreage and Canopy Growth will enter into the Amended Arrangement Agreement. The effectiveness of the Amended Arrangement Agreement and the implementation of the Amended Plan of Arrangement is also subject to additional conditions as set forth in the Proposal Agreement. Each of Acreage and Canopy Growth has made certain representations and warranties and agreed to certain covenants in the Proposal Agreement, including covenants regarding the conduct of their respective businesses prior to the Amendment Time (as defined below) that are in addition to the covenants contained in the Arrangement Agreement. In particular, the Proposal Agreement sets forth, among other things, (i) certain financial reporting obligations of Acreage from the execution of the Proposal Agreement until the earlier of the termination of the Proposal Agreement or the implementation of the Amended Plan of Arrangement (the “Interim Period”); (ii) certain restrictions on Acreage’s ability to issue any securities or incur any debt obligations during the Interim Period; (iii) a business plan for Acreage for each fiscal year ended December 31, 2020 through to December 31, 2029, and a requirement for Acreage to conduct its business in accordance with such business plan; and (iv) limitations on any public communication made by Acreage during the Interim Period. The Proposal Agreement contains certain termination rights, including (i) in favor of both Acreage and Canopy Growth, in the event that the Acreage shareholder approval is not obtained at the special meeting of Acreage shareholders, or (ii) in favor of Canopy Growth in the event that the Acreage board of directors determines, in accordance with the Proposal Agreement to make a Change in Recommendation (as defined in the Proposal Agreement). The Proposal Agreement further provides that, upon termination of the Proposal Agreement following a Change in Recommendation, Acreage will be required to pay an expense reimbursement to Canopy Growth in the amount of $3,000 ; provided however, that Acreage will not be required to make this payment if the Change in Recommendation was the result of a Purchaser Material Adverse Effect (as defined in the Arrangement Agreement). Upon satisfaction or waiver of the conditions set out in the Proposal Agreement, the Amending Agreement and the Amended Plan of Arrangement will be effective at 12:01 a.m. (Vancouver time) or such other time as the parties may mutually agree (the “Amendment Time”) on the date that the Amended Plan of Arrangement becomes effective. Pursuant to the Amended Plan of Arrangement, at the Amendment Time, Canopy Growth will make a cash payment of $37,500 to the Acreage shareholders and certain holders of securities convertible or exchangeable into shares of Acreage and Acreage will complete a capital reorganization (the “Capital Reorganization”) whereby (i) each Existing SVS will be exchanged for 70.0% of a Class E subordinate voting share (each whole share, a “Fixed Share”) and 30.0% of a Class D subordinate voting share (each whole share, a “Floating Share”); (ii) each Existing PVS will be exchanged for 28 Fixed Shares and 12 Floating Shares; and (iii) each Existing MVS will be exchanged for 70.0% of a new multiple voting share (each whole share, a “Fixed Multiple Share”) and 30.0% of a Floating Share. No fractional Fixed Shares, Fixed Multiple Shares or Floating Shares will be issued pursuant to the Capital Reorganization. Each Fixed Multiple Voting Share will be entitled to 4,300 votes at all meetings of Acreage shareholders with each Fixed Share and each Floating Share will be entitled to one vote per share at such meetings. Pursuant to the Amended Plan of Arrangement, upon the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event (the “Triggering Event Date”), Canopy Growth will, subject to the satisfaction or waiver of certain closing conditions set out in the Arrangement Agreement (i) acquire all of the issued and outstanding Fixed Shares (following the mandatory conversion of the Fixed Multiple Shares into Fixed Shares) on the basis of 30.48% of a Canopy Growth Share for each Fixed Share held at the time of the acquisition of the Fixed Shares, subject to adjustment in accordance with the terms of the Amended Plan of Arrangement (the “Canopy Call Option”); and (ii) have the right (but not the obligation) (the “Floating Call Option”), exercisable for a period of 30 days following the Triggering Event Date to acquire all of the issued and outstanding Floating Shares at a price to be determined based upon the fair market value of the Floating Shares relative to the Canopy Growth Shares on the Triggering Event Date, subject to (a) a minimum price of $6.41 ; and (b) adjustment in accordance with the terms of the Amended Plan of Arrangement, to be payable, at the option of Canopy Growth, in cash or Canopy Growth Shares. The closing of the acquisition of the Floating Shares pursuant to the Floating Call Option, if exercised, will take place concurrently with the closing of the acquisition of the Fixed Shares pursuant to the Canopy Call Option, if exercised. No fractional Canopy Growth Shares will be issued pursuant to the Amended Plan of Arrangement. The Canopy Call Option and the Floating Call Option will expire 10 years from the Amendment Time. Surety bonds The Company has indemnification obligations with respect to surety bonds primarily used as security against non-performance in the amount of $5,000 as of March 31, 2020 , for which no liabilities are recorded on the Statements of Financial Position. The Company is subject to other capital commitments and similar obligations. As of March 31, 2020 and 2019 , such amounts were not material. Contingencies As of March 31, 2020 , the Company has consulting fees payable in SVS which are contingent upon successful acquisition of certain state cannabis licenses. The Company had maximum obligations of $8,750 and 400 SVS, and no reserve for the contingencies has been recorded as of March 31, 2020 . The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company ceasing operations. While management of the Company believes that the Company is in compliance with applicable local and state regulations as of March 31, 2020 , cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties, or restrictions in the future. The Company may be, from time to time, subject to various administrative, regulatory and other legal proceedings arising in the ordinary course of business. Contingent liabilities associated with legal proceedings are recorded when a liability is probable, and the contingent liability can be reasonably estimated. New York outstanding litigation On November 2, 2018, EPMMNY LLC (“EPMMNY”) filed a complaint in the Supreme Court of the State of New York, County of New York, asserting claims against 16 defendants, including NYCANNA, Impire State Holdings LLC, NY Medicinal Research & Caring, LLC (each, a wholly-owned subsidiary of High Street) and High Street. The Index Number for the action is 655480/2018. EPMMNY alleges that it was wrongfully deprived of a minority equity interest and management role in NYCANNA by its former partner, New Amsterdam Distributors, LLC, which attempted to directly or indirectly sell or transfer EPMMNY’s alleged interest in NYCANNA to other entities in 2016 and 2017, including Impire, NYMRC and High Street. EPMMNY alleges that it is entitled to the value of its alleged minority interest in NYCANNA or minority ownership in NYCANNA. EPMMNY also alleges that certain defendants misused its alleged intellectual property and/or services, improperly solicited its employees, and aided and abetted or participated in the transfer of equity and/or business opportunities from EPMMNY. High Street intends to vigorously defend this action, which the Company firmly believes is without merit. EPMMNY alleges that it was improperly deprived of its equity stake in NYCANNA before NYCANNA was acquired by High Street. High Street is also entitled to full indemnity from the claims asserted against it by EPMMNY pursuant to the purchase agreement pertaining to its acquisition of NYCANNA and personal guarantee by the largest shareholders of the seller. The defendants filed a motion to dismiss on April 1, 2019. The motion was fully briefed and submitted to the Court on July 18, 2019, and oral argument was heard on September 6, 2019. The motion remains pending before the Court.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	RELATED PARTY TRANSACTIONS Transactions with related parties are entered into in the normal course of business and are measured at the amount established and agreed to by the parties. Related party notes receivable Acreage has certain outstanding notes receivable with related parties. Refer to Note 6 for further information. GreenAcreage The Company has an investment carried at FV-NI in GreenAcreage. The Company also has an equity method investment in the management company of GreenAcreage resulting from the CEO’s board involvement. Related party debt In December 2019, the Company’s CEO loaned $15,000 to the Company. In January 2020, he made an additional loan of $5,000 to Acreage. These amounts were subsequently repaid in March 2020. Credit agreement collateral On March 11, 2020, the Company closed $22,000 in borrowings pursuant to a loan transaction with the Lender. The maturity date is 366 days from the closing date of the loan transaction. The Company will pay monthly interest on the collateral in the form of 41 SVS through the maturity date. The Lender may put any unsold interest shares to the Company upon maturity at a price of $4.50 per share. Kevin Murphy, the Company’s Chief Executive Officer, loaned $21,000 of the $22,000 borrowed by the Company to the Lender. The loan is secured by the non-U.S. intellectual property assets, a cannabis state license and 12,000

Reportable Segments

Reportable Segments	3 Months Ended
	Mar. 31, 2020
Reportable Segments [Abstract]
Segment Reporting Disclosure [Text Block]	REPORTABLE SEGMENTS The Company prepares its segment reporting on the same basis that its Chief Operating Decision Maker manages the business and makes operating decisions. The Company operates under one operating segment, which is its only reportable segment: the production and sale of cannabis products. The Company’s measure of segment performance is net income, and derives its revenue primarily from the sale of cannabis products, as well as related management or consulting services which were not material in all periods presented. All of the Company’s operations are located in the United States.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events [Text Block]	SUBSEQUENT EVENTS Terminated Transactions On April 3, 2020, the Company announced the termination of the securities purchase agreement among Greenleaf Compassionate Care Center, Inc., GCCC Management, LLC (“GCCCM”), the equity holders of GCCCM and high Street Capital Partners, LLC relating to the proposed acquisition of a dispensary in Rhode Island. Additionally, the merger agreement entered into with Deep Roots Medical LLC was terminated. Sale of Acreage North Dakota On May 8, 2020, the Company sold all equity interests in Acreage North Dakota, LLC, a medical cannabis dispensary holder and operator, for $1,000 . Standby Equity Distribution Definitive Agreement Effective May 29, 2020, the Company reached a definitive agreement with an institutional lender for $50,000 of financing commitments under a Standby Equity Distribution Agreement. The investor commits to purchase up to $50,000 of subordinate voting shares of the Company at a purchase price of 95% of the market price over the course of 24 months from the effective date. Convertible Note Effective May 29, 2020, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with YA II PN, Ltd. (the “Investor”), pursuant to which the Company sold and issued $11,000 in principal amount under a secured convertible debenture, with gross proceeds to the Company of $10,000 before transaction fees (the “Convertible Debenture”). The Convertible Debenture will bear interest at 15% per annum and is secured by the Company’s medical cannabis dispensaries in Connecticut. The Convertible Debenture is convertible by the holder in whole or in part after September 30, 2020. Prior to September 30, 2020, the holder may convert only $550 of principal amount. The Convertible Debenture is convertible into Class A Subordinate Voting Shares of the Company at a conversion price of $1.68 per share, subject to the conversion limitations described above. The Company has the right to redeem up to 95% of the principal amount on or prior to September 29, 2020 without penalty. In connection with the Securities Purchase Agreement, the Company executed a registration rights agreement (the “Registration Rights Agreement”) pursuant to which it is required to file a registration statement (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) for the resale of certain of the shares of the Company. Pursuant to the Registration Rights Agreement, the Company is required to meet certain obligations with respect to, among other things, the timeliness of the filing and effectiveness of the Registration Statement. The Company is obligated to file the Registration Statement no later than 30 days following May 29, 2020 and to use its best efforts have it declared effective by the SEC no later than 90 days after filing. Acreage filed the Registration Statement on June 22, 2020. Secured Bridge Loan Agreement On June 16, 2020, the Company entered into a short-term definitive funding agreement with an institutional investor for gross proceeds of $15,000 (less transaction costs of approximately $943 ). The secured note has a maturity date of four months and bears an interest rate of 60% per annum. It is secured by, among other items, the Company’s cannabis operations in Illinois, New Jersey and Florida, as well as the Company’s U.S. intellectual property. In the event of default, the Company is obligated to pay the lender an additional fee of $6,000 . The Company may pre-pay the secured note without penalty or premium at any time following the 90 th day after closing. Acquisition of New Jersey Medical Operations On June 26, 2020, the Company announced the closing of the transactions contemplated by the previously announced Reorganization Agreement, dated November 15, 2019, among the Company, Compassionate Care Foundation, Inc. (“CCF”), a New Jersey vertically integrated medical cannabis nonprofit corporation, and certain affiliates thereof, pursuant to which Acreage CCF New Jersey, LLC, a subsidiary of HSCP, acquired 100% of the operations of CCF. In accordance with the terms of the Reorganization Agreement, Acreage assumed all debts, liabilities and obligations of CCF, including fees, costs and expenses to be incurred by CCF in connection with the dissolution and wind-up of CCF and paid to the former trustees of CCF an aggregate total of $10,000 at closing. Proposed Amendment to Arrangement with Canopy Growth Corporation

Quarterly Financial Data (unaud

Quarterly Financial Data (unaudited)	3 Months Ended
	Mar. 31, 2020
Quarterly Financial Data (unaudited) [Abstract]
Quarterly Financial Information [Text Block]	Basic earnings per share are computed by dividing net loss attributable to common shareholders of the Company by the weighted average number of outstanding for the period. Diluted earnings per share are calculated based on the weighted number of outstanding common shares plus the dilutive effect of stock options and warrants, as if they were exercised, and restricted stock units and profits interests, as if they vested and NCI convertible units, as if they converted. Basic and diluted loss per share is as follows: Three months ended March 31, 2020 March 31, 2019 Net loss attributable to common shareholders of the Company $ (171,954 ) $ (23,377 ) Weighted average shares outstanding - basic 92,902 79,440 Effect of dilutive securities — — Weighted average shares - diluted 92,902 79,440 Net loss per share attributable to common shareholders of the Company - basic $ (1.85 ) $ (0.29 ) Net loss per share attributable to common shareholders of the Company - diluted $ (1.85 ) $ (0.29 ) During the three months ended March 31, 2020 , 8,125 warrants, 9,158 restricted share units, 5,067 stock options and 24,612 NCI convertible units were excluded from the calculation of net loss per share attributable to common shareholders of the Company - diluted as they were anti-dilutive. During the three months ended March 31, 2019 , 2,259 warrants, 1,830 restricted share units, 4,902 stock options, 1,200 profits interests and 27,397

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Significant Accounting Policies [Abstract]
Description of New Accounting Pronouncements Not yet Adopted [Text Block]	In June 2016, the FASB issued ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which was subsequently revised by ASU 2018-19. The ASU introduces a new model for assessing impairment on most financial assets. Entities will be required to use a forward-looking expected loss model, which will replace the current incurred loss model, which will result in earlier recognition of allowance for losses. The ASU will be effective for the Company’s first interim period of fiscal 2023, and the Company is currently evaluating the impact of the new standard.
Substantial Doubt about Going Concern [Text Block]	Basis of presentation and going concern The Unaudited Condensed Consolidated Financial Statements of Acreage have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting only of normal recurring adjustments necessary for a fair presentation have been reflected in these Unaudited Condensed Consolidated Financial Statements. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2020. As reflected in the financial statements, the Company had an accumulated deficit as of March 31, 2020, as well as a net loss and net cash used in operating activities for the reporting period then ended. These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance of these financial statements. However, management believes that substantial doubt about the Company’s ability to meet our obligations for the next twelve months from the date these financial statements were issued has been alleviated due to, but not limited to, (i) capital raised between January and June 2020, (ii) access to future capital commitments (see Note 13), (iii) continued sales growth from our consolidated operations, (iv) latitude as to the timing and amount of certain operating expenses as well as capital expenditures, (v) restructuring plans that have already been put in place to improve the Company’s profitability and (vi) the Standby Equity Distribution Agreement described in Note 17 of the Unaudited Condensed Consolidated Financial Statements. If the Company is unable to raise additional capital whenever necessary, it may be forced to decelerate or curtail its footprint buildout or other operational activities until such time as additional capital becomes available. Such limitation of the Company’s activities would allow it to slow its rate of spending and extend its use of cash until additional capital is raised. However, management cannot provide any assurances that we will be successful in accomplishing any of our plans. Management also cannot provide any assurance as to unforeseen circumstances that could occur at any time within the next twelve months or thereafter which could increase our need to raise additional capital on an immediate basis.
Use of estimates	Use of estimates The preparation of the Company’s Unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts that are reported in the Unaudited Condensed Consolidated Financial Statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates inherent in the preparation of the accompanying Unaudited Condensed Consolidated Financial Statements include the fair value of assets acquired and liabilities assumed in business combinations, assumptions relating to equity-based compensation expense, estimated useful lives for property, plant and equipment and intangible assets, the valuation allowance against deferred tax assets and the assessment of potential impairment charges on goodwill, intangible assets and investments in equity and notes receivable.
Emerging Growth Company [Policy Text Block]	Emerging growth company We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies.
Functional and presentation currency	Functional and presentation currency The Unaudited Condensed Consolidated Financial Statements and the accompanying notes are expressed in U.S. dollars. Financial metrics are presented in thousands. Other metrics, such as shares outstanding, are presented in thousands unless otherwise noted.
Basis of consolidation	Basis of consolidation Our Unaudited Condensed Consolidated Financial Statements include the accounts of Acreage, its subsidiaries and variable interest entities (“VIEs”) where we are considered the primary beneficiary, if any, after elimination of intercompany accounts and transactions. Investments in entities in which the Company has significant influence, but less than a controlling financial interest, are accounted for using the equity method. Our proportionate share of net income or loss of the entity is recorded in Income (loss) from investments, net in the Consolidated Statements of Operations.
Earnings Per Share, Policy [Policy Text Block]	oss per share Net loss per share represents the net loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis. Basic and diluted loss per share are the same as of March 31, 2020 and 2019 as the issuance of shares upon conversion, exercise or vesting of outstanding units would be anti-dilutive in each period. There were 46,962 and 37,588 anti-dilutive shares outstanding as of March 31, 2020 and 2019

Acquisitions (Tables)

Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2020
Acquisitions [Abstract]
2018 PPA [Table Text Block]	Purchase Price Allocation Thames Valley (1) NCC (2) Total Assets acquired: Cash and cash equivalents $ 106 $ 696 $ 802 Inventory 39 170 209 Other current assets 1 36 37 Capital assets, net — 539 539 Goodwill 3,596 4,192 7,788 Intangible assets - cannabis licenses 14,850 2,500 17,350 Other non-current assets — 25 25 Liabilities assumed: Accounts payable and accrued liabilities (121 ) (24 ) (145 ) Other current liabilities — (621 ) (621 ) Deferred tax liability (3,399 ) (461 ) (3,860 ) Other liabilities — (175 ) (175 ) Fair value of net assets acquired $ 15,072 $ 6,877 $ 21,949 Consideration paid: Cash 15,072 — 15,072 Deferred acquisition costs and deposits — 100 100 Subordinate Voting Shares — 3,948 3,948 Settlement of pre-existing relationship — 830 830 Fair value of previously held interest — 1,999 1,999 Total consideration $ 15,072 $ 6,877 $ 21,949 Subordinate Voting Shares issued — 211 211

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Intangibles and Goodwill [Abstract]
Intangible Assets [Table Text Block]	Intangibles March 31, 2020 December 31, 2019 Finite-lived intangible assets: Management contracts $ 19,580 $ 52,438 Customer relationships — 4,600 Developed technology — 3,100 19,580 60,138 Accumulated amortization on finite-lived intangible assets: Management contracts (3,639 ) (5,750 ) Customer relationships — (649 ) Developed technology — (114 ) (3,639 ) (6,513 ) Finite-lived intangible assets, net 15,941 53,625 Indefinite-lived intangible assets Cannabis licenses 139,549 232,347 Total intangibles, net $ 155,490 $ 285,972
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]		Amortization of Intangibles 2020 2021 2022 2023 2024 Amortization expense $ 1,623 $ 2,164 $ 2,164 $ 2,164 $ 2,164
Schedule of Goodwill [Table Text Block]	Goodwill Total December 31, 2019 $ 105,757 Acquisitions — Impairment (76,890 ) March 31, 2020 $ 28,867

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2020
Investments [Abstract]
Investment Holdings, Schedule of Investments [Table Text Block]	Investments March 31, 2020 December 31, 2019 Investments held at FV-NI 4,607 4,376 Equity method investments 118 123 Total long-term investments $ 4,725 $ 4,499
Investment Income [Table Text Block]	Investment income Three Months Ended March 31, 2020 2019 Short-term investments $ — $ 500 Investments held at FV-NI 240 1,203 Equity method investments (6 ) 1,024 Income from investments, net $ 234 $ 2,727

Notes Receivable (Tables)

Notes Receivable (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Receivable [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	March 31, 2020 December 31, 2019 Notes receivable $ 99,105 $ 75,851 Interest receivable 4,731 5,774 Total notes receivable $ 103,836 $ 81,625 Less: Notes receivable, current 2,123 2,146 Notes receivable, non-current $ 101,713 $ 79,479
Schedule of Line of Credit Facilities [Table Text Block]	Lines of Credit Balance as of Counterparty Maximum Obligation Interest Rate March 31, 2020 December 31, 2019 Greenleaf (1) $ 29,286 3.25% - 4.75% $ 27,277 $ 22,569 CWG Botanicals, Inc. ("CWG") (2) 12,000 8% 9,466 9,152 Compassionate Care Foundation, Inc. (“CCF”) (3) 12,500 18% 7,952 7,152 Prime Alternative Treatment Center, Inc. ("PATC") (4) 4,650 15% 4,650 4,650 Patient Centric of Martha’s Vineyard, Ltd. (“PCMV”) (5) 9,000 15% 6,209 5,758 Health Circle, Inc. (6) 8,000 15% 4,331 3,988 Total $ 75,436 $ 59,885 $ 53,269

Capital Assets, net (Tables)

Capital Assets, net (Tables)	3 Months Ended
	Mar. 31, 2020
Capital Assets, net [Abstract]
Property, Plant and Equipment [Table Text Block]	March 31, 2020 December 31, 2019 Land $ 11,611 $ 9,839 Building 37,516 34,522 Right-of-use asset, finance leases 5,980 5,954 Construction in progress 17,125 17,288 Furniture, fixtures and equipment 27,897 21,019 Leasehold improvements 23,240 22,682 Capital assets, gross $ 123,369 $ 111,304 Less: accumulated depreciation (6,676 ) (5,257 ) Capital assets, net $ 116,693 $ 106,047

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Finance Lease, Liability, Maturity [Table Text Block]	Maturity of lease liabilities Operating Leases Finance Leases 2020 $ 6,414 $ 652 2021 8,629 873 2022 8,484 893 2023 8,310 914 2024 8,030 936 Thereafter 53,986 18,740 Total lease payments $ 93,853 $ 23,008 Less: imputed interest 39,584 17,002 Present value of lease liabilities $ 54,269 $ 6,006 Weighted average remaining lease term (years) 12 24 Weighted average discount rate 10% 14%
Lease, Cost [Table Text Block]	Balance Sheet Information Classification March 31, 2020 December 31, 2019 Right-of-use assets Operating Operating lease right-of-use assets $ 55,411 $ 51,950 Finance Capital assets, net 5,764 5,832 Total right-of-use assets $ 61,175 $ 57,782 Lease liabilities Current Operating Operating lease liability, current $ 3,253 $ 2,759 Financing Debt, current 74 49 Non-current Operating Operating lease liability, non-current 51,016 47,522 Financing Debt, non-current 5,932 6,083 Total lease liabilities $ 60,275 $ 56,413 Statement of Operations Information Classification Three Months Ended Three Months Ended March 31, 2019 Short-term lease expense General and administrative $ 317 $ 298 Operating lease expense General and administrative 2,020 956 Finance lease expense: Amortization of right of use asset Depreciation and amortization 95 2 Interest expense on lease liabilities Interest expense 215 12 Sublease income Other (loss) income, net (16 ) (43 ) Net lease cost $ 2,314 $ 927 Statement of Cash Flows Information Classification Three Months Ended Three Months Ended March 31, 2019 Cash paid for operating leases Net cash used in operating activities 1,493 522 Cash paid for finance leases - interest Net cash used in operating activities 196 12

Inventory (Tables)

Inventory (Tables)	3 Months Ended
	Mar. 31, 2020
Inventory [Abstract]
Schedule of Inventory, Current [Table Text Block]	March 31, 2020 December 31, 2019 Retail inventory $ 2,103 $ 1,784 Wholesale inventory 13,816 11,993 Cultivation inventory 3,235 3,021 Supplies & other 1,903 1,285 Total $ 21,057 $ 18,083

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2020
Debt [Abstract]
Schedule of Debt [Table Text Block]	Debt balances March 31, 2020 December 31, 2019 NCCRE loan $ 487 $ 492 Seller’s notes 2,744 2,810 Related party debt — 15,000 Financing liability 19,052 19,052 Finance lease liabilities 6,006 6,132 SAF loan 19,438 — SAF loan collateral (related party) 22,254 — Total debt $ 69,981 $ 43,486 Less: current portion of debt 22,514 15,300 Total long-term debt $ 47,467 $ 28,186
Interest Income and Interest Expense Disclosure [Table Text Block]	Interest Expense Three Months Ended March 31, 2020 2019 NCCRE loan 5 5 Seller’s notes 72 101 Interest expense on financing liability 591 — Interest expense on finance lease liability 215 12 Interest expense on SAF loan 89 — Interest expense on SAF loan collateral (related party) 254 — Total interest expense $ 1,226 $ 118

Shareholders' Equity and Non-_2

Shareholders' Equity and Non-Controlling Interests (Tables)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Shareholders' Equity and Non-Controlling Interests [Abstract]
Schedule of Stock by Class [Table Text Block]	Shareholders’ Equity Subordinate Voting Shares Subordinate Voting Shares Held in Treasury Proportionate Voting Shares (as converted) Multiple Voting Shares Total Shares Outstanding December 31, 2019 68,177 (842 ) 23,143 168 90,646 Issuances 6,671 — — — 6,671 NCI conversions 113 — — — 113 PVS conversions 294 — (294 ) — — March 31, 2020 75,255 (842 ) 22,849 168 97,430	Shareholders’ Equity Subordinate Voting Shares Subordinate Voting Shares Held in Treasury Proportionate Voting Shares (as converted) Multiple Voting Shares Total Shares Outstanding December 31, 2018 21,943 (842 ) 57,895 168 79,164 Issuances 413 — — — 413 NCI conversions 643 — — — 643 PVS conversions 21,472 — (21,472 ) — — March 31, 2019 44,471 (842 ) 36,423 168 80,220
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Warrants Three Months Ended March 31, 2020 2019 Beginning balance 2,040 2,259 Granted 6,085 — Expired — — Ending balance 8,125 2,259
Noncontrolling Interest, Period Increase (Decrease) [Table Text Block]	HSCP net asset reconciliation March 31, 2020 December 31, 2019 Current assets $ 68,038 $ 55,296 Non-current assets 452,280 584,812 Current liabilities (59,525 ) (46,434 ) Non-current liabilities (91,035 ) (75,219 ) Other NCI balances (491 ) (1,041 ) Accumulated equity-settled expenses (148,310 ) (111,934 ) Net assets $ 220,957 $ 405,480 HSCP/USCo2 ownership % of HSCP 20.17 % 21.64 % Net assets allocated to USCo2/HSCP $ 44,567 $ 87,746 Net assets attributable to other NCIs 491 1,041 Total NCI $ 45,058 $ 88,787 Three Months Ended March 31, HSCP Summarized Statement of Operations 2020 2019 Net loss allocable to HSCP/USCo2 $ (235,203 ) $ (28,958 ) HSCP/USCo2 weighted average ownership % of HSCP 21.15 % 25.63 % Net loss allocated to HSCP/USCo2 $ (49,745 ) $ (7,422 ) Net loss allocated to other NCIs (530 ) (5 ) Net loss attributable to NCIs $ (50,275 ) $ (7,427 )
Schedule of Conversions of Stock [Table Text Block]	Three Months Ended March 31, Convertible Units 2020 2019 Beginning balance 25,035 27,340 Issuance of NCI units — 198 Vested LLC C-1s canceled (1,310 ) (123 ) LLC C-1s vested 1,000 625 NCI units settled in cash — (643 ) NCI units converted to Pubco (113 ) — Ending balance 24,612 27,397

Equity-Based Compensation (Tabl

Equity-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Equity-based compensation [Abstract]
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	Equity-based compensation expense Three Months Ended March 31, 2020 2019 Equity-based compensation - Plan $ 19,290 $ 18,881 Equity-based compensation - other 15,447 96 Total equity-based compensation expense $ 34,737 $ 18,977
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Three Months Ended Restricted Share Units (Fair value information expressed in whole dollars) RSUs Weighted Average Grant Date Fair Value Unvested, beginning of period 7,843 $ 15.10 Granted (1) 4,155 3.68 Forfeited (1,593 ) 14.48 Vested (1,247 ) 8.00 Unvested, end of period 9,158 $ 10.99
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Three Months Ended Stock Options (Exercise price expressed in whole dollars) Options Weighted Average Exercise Price Options outstanding, beginning of period 5,607 $ 21.56 Granted 191 5.75 Forfeited (731 ) 16.39 Exercised — — Options outstanding, end of period 5,067 $ 21.71 Options exercisable, end of period 1,718 $ 24.80
Share-based payment arrangements, LLC profits interests [Table Text Block]	Three Months Ended Profits Interests (Fair value information expressed in whole dollars) Number of Units Weighted Average Grant Date Fair Value Unvested, beginning of period 1,000 $ 0.43 Class C-1 units granted — — Class C-1 units canceled — — Class C-1 vested (1,000 ) 0.43 Unvested, end of period — $ —

Nature of Operations (Details)

Nature of Operations (Details) - $ / shares	Mar. 02, 2020	Feb. 10, 2020
Nature of Operations [Abstract]
Strike price per broker warrant	$ 5.80	$ 4.93

Significant Accounting Polici_3

Significant Accounting Policies (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Property, Plant and Equipment [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	46,962	37,588

Acquisitions PPA Tables (Detail

Acquisitions PPA Tables (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 04, 2019	Jan. 29, 2019	May 31, 2018
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents		$ 802
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory		209
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other		37
Business Combination, Notes receivable acquired		539
Goodwill of acquired entities		7,788
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets		17,350
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable		(145)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities		(3,860)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other		(175)
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net		21,949
Business Combination, Consideration Transferred, Debt		3,948
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value		830
Business Combination, Consideration Transferred		$ 21,949
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		211
Deferred acquisition costs and deposits	$ 0	$ 300
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value consideration		1,999
HSCP LLC Membership Units [Member]
Business Acquisition [Line Items]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		15,072
Common Stock [Member]
Business Acquisition [Line Items]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		100
D&B [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents					$ 106
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory					39
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other					1
Business Combination, Notes receivable acquired					0
Goodwill of acquired entities					3,596
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets					14,850
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets					0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable					(121)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities					(3,399)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other					0
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net					15,072
Business Combination, Consideration Transferred, Debt		0
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value		0
Business Combination, Consideration Transferred		$ 15,072
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		0
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value consideration		$ 0
D&B [Member] | HSCP LLC Membership Units [Member]
Business Acquisition [Line Items]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		15,072
D&B [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		0
WPMC [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents					696
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory					170
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other					36
Business Combination, Notes receivable acquired					539
Goodwill of acquired entities					4,192
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets					2,500
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets		25			25
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable					(24)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities					(461)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other					(175)
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net					$ 6,877
Business Combination, Consideration Transferred, Debt		3,948
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value		830
Business Combination, Consideration Transferred		$ 6,877
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		211
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain		$ 999
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value consideration		1,999
WPMC [Member] | HSCP LLC Membership Units [Member]
Business Acquisition [Line Items]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		0
WPMC [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		$ 100
Thames Valley [Member]
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired				100.00%
NCC [Member]
Business Acquisition [Line Items]
Business Acquisition, Share Price			$ 18.70

Acquisitions 2018 Pro forma (De

Acquisitions 2018 Pro forma (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Total revenues, net	$ 24,225	$ 12,897
Gross Profit	9,954	5,320
Operating Income (Loss)	(251,282)	(32,013)
Net loss	$ (222,229)	$ (30,804)

Acquisitions Deferred Acquisiti

Acquisitions Deferred Acquisition Costs and Deposits (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Schedule of Deferred Acquisition Costs and Deposits [Line Items]
Deferred acquisition costs and deposits	$ 0	$ 300

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill Intangible Assets Table (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$ 92,798,000	$ 0
Impairment of Intangible Assets, Finite-lived	8,324,000	$ 0
Finite-Lived Intangible Assets, Gross	19,580,000		$ 60,138,000
Finite-Lived Intangible Assets, Accumulated Amortization	(3,639,000)		(6,513,000)
Finite-Lived Intangible Assets, Net	15,941,000		53,625,000
Indefinite-lived Intangible Assets (Excluding Goodwill)	139,549,000		232,347,000
Intangible assets, net	155,490,000		285,972,000
Management Service [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	19,580,000		52,438,000
Finite-Lived Intangible Assets, Accumulated Amortization	(3,639,000)		(5,750,000)
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	0		4,600,000
Finite-Lived Intangible Assets, Accumulated Amortization	0		(649,000)
Technology-Based Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	0		3,100,000
Finite-Lived Intangible Assets, Accumulated Amortization	$ 0		$ (114,000)

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 11, 2020	Mar. 06, 2020	Feb. 10, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$ 92,798,000	$ 0
Impairment of Intangible Assets, Finite-lived	8,324,000	0
Acquired Indefinite-lived Intangible Assets [Line Items]
Goodwill, Impairment Loss	65,304,000	0
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value		830,000
Intangible Purchase, Notes receivable acquired		539,000
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability	31,316
Convertible Debt	18,800,000	0	$ 22,000	$ 18,800,000	$ 27,887
Tangible Asset Impairment Charges	11,586,000
Other Asset Impairment Charges	9,395,000
Amortization of Intangible Assets	$ 1,165,000	$ 661,000

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill Future Amortization Table (Details) $ in Thousands	Mar. 31, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	$ 1,623
Finite-Lived Intangible Assets, Amortization Expense, Year Two	2,164
Finite-Lived Intangible Assets, Amortization Expense, Year Three	2,164
Finite-Lived Intangible Assets, Amortization Expense, Year Four	2,164
Finite-Lived Intangible Assets, Amortization Expense, Year Five	$ 2,164

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill Goodwill Table (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Goodwill [Line Items]
Goodwill	$ 28,867	$ 105,757
Goodwill, Period Increase (Decrease)	0
Goodwill, Purchase Accounting Adjustments	$ (76,890)

Investments Investment Holdings

Investments Investment Holdings Table (Details) - USD ($)	Mar. 31, 2020	Mar. 11, 2020	Dec. 31, 2019
Investment Holdings [Line Items]
Equity Securities, FV-NI	$ 4,607,000	$ 5,700	$ 4,376,000
Equity Method Investments	118,000		123,000
Long-term investments	$ 4,725,000		$ 4,499,000

Investments Investment Income T

Investments Investment Income Table (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net Investment Income [Line Items]
Income from investments, net	$ 234	$ 2,727
Short-term Debt [Member]
Net Investment Income [Line Items]
Income from investments, net	0	500
Equity securities, FV-NI [Member]
Net Investment Income [Line Items]
Income from investments, net	240	1,203
Equity Method Investments [Member]
Net Investment Income [Line Items]
Income from investments, net	$ (6)	$ 1,024

Investments Investments Narrati

Investments Investments Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Investments [Abstract]
Treasury bill interest rate range, minimum	2.20%
Treasury bill interest rate range, maximum	2.40%
Proceeds from purchase of short-term investments	$ 0	$ 74,768

Notes Receivable Notes Receivab

Notes Receivable Notes Receivable Table (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Notes Receivable [Abstract]
Financing Receivable, Not Past Due	$ 99,105	$ 75,851
Interest Receivable	4,731	5,774
Notes receivable, including accrued interest	103,836	81,625
Notes receivable, current	2,123	2,146
Notes receivable, non-current	$ 101,713	$ 79,479

Notes Receivable Notes Narrativ

Notes Receivable Notes Narrative (Details) - USD ($)	Mar. 06, 2020	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Mar. 11, 2020	Feb. 10, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income from loans receivable		$ 1,647,000	$ 730,000
Payments to Acquire Notes Receivable		11,560,000	8,629,000
Interest Receivable		4,731,000		$ 5,774,000
Allowance for Loan and Lease Losses, Write-offs		8,161,000	0
Convertible Debt	$ 18,800,000	18,800,000	0		$ 22,000	$ 27,887
General and administrative		13,032,000	$ 10,158,000
Equity Securities, FV-NI		4,607,000		4,376,000	5,700
Debt, current	$ 1,900	22,514,000		15,300,000	$ 21,000
Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest Receivable		161
West Coast social equity entity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Payments to Acquire Notes Receivable				$ 8,000
Investment Interest Rate				8.00%
Common Stock [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Stock Issued During Period, Shares, Other	900		12,000
Securities Financing Transaction, Cost [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
General and administrative		$ 120

Notes Receivable Lines of Credi

Notes Receivable Lines of Credit Table (Details) - USD ($) $ in Thousands	Jun. 24, 2020	Mar. 31, 2020	Dec. 31, 2019
Line of Credit Facility [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired	430000.00%
Guarantor Obligations, Maximum Exposure, Undiscounted		$ 75,436
Long-term Line of Credit		59,885	$ 53,269
Greenleaf [Member]
Line of Credit Facility [Line Items]
Guarantor Obligations, Maximum Exposure, Undiscounted		29,286
Long-term Line of Credit		27,277	22,569
CWG [Member]
Line of Credit Facility [Line Items]
Guarantor Obligations, Maximum Exposure, Undiscounted		$ 12,000
Line of Credit Facility, Interest Rate at Period End		8.00%
Long-term Line of Credit		$ 9,466	9,152
CCF [Member]
Line of Credit Facility [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired		100.00%
Guarantor Obligations, Maximum Exposure, Undiscounted		$ 12,500
Line of Credit Facility, Interest Rate at Period End		18.00%
Long-term Line of Credit		$ 7,952	7,152
Pending acquisition, percent of voting interests note will convert into		54.00%
Pending acquisition, amount owed for remaining ownership interests		$ 10,000
Pending acquisition, percent of voting interests to be purchased		46.00%
PATC [Member]
Line of Credit Facility [Line Items]
Guarantor Obligations, Maximum Exposure, Undiscounted		$ 4,650
Line of Credit Facility, Interest Rate at Period End		15.00%
Long-term Line of Credit		$ 4,650	4,650
PCMV [Member]
Line of Credit Facility [Line Items]
Guarantor Obligations, Maximum Exposure, Undiscounted		$ 9,000
Line of Credit Facility, Interest Rate at Period End		15.00%
Long-term Line of Credit		$ 6,209	5,758
Health Circle [Member]
Line of Credit Facility [Line Items]
Guarantor Obligations, Maximum Exposure, Undiscounted		$ 8,000
Line of Credit Facility, Interest Rate at Period End		15.00%
Long-term Line of Credit		$ 4,331	$ 3,988
Minimum [Member] | Greenleaf [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Interest Rate at Period End		3.25%
Maximum [Member] | Greenleaf [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Interest Rate at Period End		5.00%

Capital Assets, net (Details)

Capital Assets, net (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Depreciation	$ 902	$ 247
Land	11,611		$ 9,839
Buildings and Improvements, Gross	37,516		34,522
Finance Lease, Right-of-Use Asset	5,980		5,954
Construction in Progress, Gross	17,125		17,288
Furniture and Fixtures, Gross	27,897		21,019
Leasehold Improvements, Gross	23,240		22,682
Property, Plant and Equipment, Gross	123,369		111,304
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	(6,676)		(5,257)
Capital assets, net	116,693		$ 106,047
Depreciation capitalized to inventory	(600)	(410)
Sale Leaseback Transaction, Net Proceeds, Financing Activities	$ 21,000	$ 0

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Leases [Abstract]
Operating lease right-of-use assets	$ 55,411	$ 51,950	$ 51,950
Finance Lease, Right-of-Use Asset	5,980		5,954
Finance Lease, Right-of-Use Asset	5,764	5,832
Total right-of-use assets	61,175	57,782
Operating lease liability, current	3,253	2,759	2,759
Finance Lease, Liability, Current	74	49
Operating lease liability, non-current	51,016	47,522	$ 47,522
Finance Lease, Liability, Noncurrent	5,932	6,083
Total lease liabilities	60,275	56,413
Short-term Lease, Cost	317	298
Operating Lease, Expense	2,020	956
Finance Lease, Right-of-Use Asset, Amortization	95	2
Finance Lease, Interest Expense	215	12
Sublease Income	(16)	(43)
Lease, Cost	2,314	927
Operating Lease, Payments	1,493	522
Finance Lease, Interest Payment on Liability	$ 196	$ 12

Leases Lease Maturities Table (

Leases Lease Maturities Table (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months	$ 6,414
Finance Lease, Liability, Payments, Due Next Twelve Months	652
Lessee, Operating Lease, Liability, Payments, Due Year Two	8,629
Finance Lease, Liability, Payments, Due Year Two	873
Lessee, Operating Lease, Liability, Payments, Due Year Three	8,484
Finance Lease, Liability, Payments, Due Year Three	893
Lessee, Operating Lease, Liability, Payments, Due Year Four	8,310
Finance Lease, Liability, Payments, Due Year Four	914
Lessee, Operating Lease, Liability, Payments, Due Year Five	8,030
Finance Lease, Liability, Payments, Due Year Five	936
Lessee, Operating Lease, Liability, Payments, Due after Year Five	53,986
Finance Lease, Liability, Payments, Due after Year Five	18,740
Lessee, Operating Lease, Liability, Payments, Due	93,853
Finance Lease, Liability, Payment, Due	23,008
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	39,584
Finance Lease, Liability, Undiscounted Excess Amount	17,002
Operating Lease, Liability	54,269
Finance Lease, Liability	$ 6,006	$ 6,132
Operating Lease, Weighted Average Remaining Lease Term	12 years
Finance Lease, Weighted Average Remaining Lease Term	24 years
Operating Lease, Weighted Average Discount Rate, Percent	10.00%
Finance Lease, Weighted Average Discount Rate, Percent	14.00%

Inventory (Details)

Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Inventory [Line Items]
Retail Related Inventory	$ 2,103	$ 1,784
Wholesale inventory	13,816	11,993
Cultivation inventory	3,235	3,021
Supplies and other inventory	1,903	1,285
Inventory	$ 21,057	$ 18,083

Debt Schedule of Debt Table (De

Debt Schedule of Debt Table (Details) - USD ($)	Mar. 31, 2020	Mar. 11, 2020	Mar. 06, 2020	Jan. 01, 2020	Dec. 31, 2019	Dec. 31, 2016
Debt Instrument, Redemption [Line Items]
Loans Payable	$ 487,000				$ 492,000	$ 550,000
Notes Payable	2,744,000				2,810,000
Related Party Debt	0	$ 21,000		$ 5,000	15,000,000
Sale Leaseback Transaction, Amount Due under Financing Arrangement	19,052,000				19,052,000
Finance Lease, Liability	6,006,000				6,132,000
Collateralized Financings	19,438,000				0
Debt Instrument, Collateral Amount	22,254,000				0
Debt, Long-term and Short-term, Combined Amount	69,981,000				43,486,000
Debt, current	22,514,000	21,000	$ 1,900		15,300,000
Debt, non-current	$ 47,467,000	$ 100,000			$ 28,186,000

Debt Interest Income and Intere

Debt Interest Income and Interest Expense Disclosure (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Debt Instrument [Line Items]
Financing Interest Expense	$ 591	$ 0
Finance Lease, Interest Expense	215	12
Interest Expense, Borrowings	89	0
Interest Expense, Long-term Debt	254	0
Interest expense	1,226	118
NCCRE Loan [Member]
Debt Instrument [Line Items]
Interest Expense, Debt	5	5
Seller's notes [Member]
Debt Instrument [Line Items]
Interest Expense, Debt	$ 72	$ 101

Debt Debt Narrative (Details)

Debt Debt Narrative (Details) - USD ($)	Jun. 24, 2020	Mar. 13, 2020	Mar. 11, 2020	Mar. 02, 2020	Feb. 20, 2020	Feb. 10, 2020	Mar. 31, 2020	Mar. 06, 2020	Jan. 01, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2016
Debt Instrument [Line Items]
Collateralized Financings							$ 19,438,000			$ 0
Convertible Debt			$ 22,000			$ 27,887	$ 18,800,000	$ 18,800,000			$ 0
SVS secured for loan							12,000
Strike price per broker warrant				$ 5.80		$ 4.93
Loans Payable							$ 487,000			492,000		$ 550,000
Restricted cash			22,000				22,095,000			95,000
Proceeds from Related Party Debt			21,000				0		$ 5,000	15,000,000
Debt Instrument, Collateral Amount							22,254,000			0
Debt, current			21,000				22,514,000	$ 1,900		15,300,000
Debt, non-current			$ 100,000				$ 47,467,000			$ 28,186,000
RTO expense settled in shares			41			1	1
NCCRE Loan [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			3.55%									3.70%
Seller's notes [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage							3.50%
Seller's notes [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage							10.00%
Restricted Stock Units (RSUs) [Member]
Debt Instrument [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 6.41	$ 2.15	$ 4.50		$ 5.11		$ 3.68

Shareholders' Equity and Non-_3

Shareholders' Equity and Non-Controlling Interests Narrative (Details) - shares	Mar. 11, 2020	Feb. 10, 2020	Mar. 31, 2020	Mar. 31, 2019	Jun. 24, 2020	Dec. 31, 2019	Dec. 31, 2018
Class of Stock [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired					430000.00%
Class of Warrant or Right, Outstanding		6,085,000	8,125,000	2,259,000		2,040,000	2,259,000
RTO-related issuances, net, shares	41	1	1
Common Class C [Member]
Class of Stock [Line Items]
Redemption of membership units at RTO, shares			0	0

Shareholders' Equity and Non-_4

Shareholders' Equity and Non-Controlling Interests Schedule of Stock by Class (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Class of Stock [Line Items]
Common Stock, Shares, Outstanding			90,646	97,430
Treasury Stock, Common, Shares			(842)	(842)
Common Class A [Member]
Class of Stock [Line Items]
Common Stock, Shares, Outstanding	75,255	44,471	68,177	21,943
Redemption of membership units at RTO, shares	6,671	413
Partners' Capital Account, Units, Sold in Private Placement	113	643
Stockholders' Equity, Other Shares	294	21,472
Treasury Stock, Common [Member]
Class of Stock [Line Items]
Treasury Stock, Common, Shares	(842)	(842)	(842)	(842)
Redemption of membership units at RTO, shares	0	0
Partners' Capital Account, Units, Sold in Private Placement	0	0
Stockholders' Equity, Other Shares	0	0
Common Class B [Member]
Class of Stock [Line Items]
Common Stock, Shares, Outstanding	22,849	36,423	23,143	57,895
Redemption of membership units at RTO, shares	0	0
Partners' Capital Account, Units, Sold in Private Placement	0	0
Stockholders' Equity, Other Shares	(294)	(21,472)
Common Class C [Member]
Class of Stock [Line Items]
Common Stock, Shares, Outstanding	168	168	168	168
Redemption of membership units at RTO, shares	0	0
Partners' Capital Account, Units, Sold in Private Placement	0	0
Stockholders' Equity, Other Shares	0	0
Common Stock [Member]
Class of Stock [Line Items]
Common Stock, Shares, Outstanding	97,430	80,220	90,646	79,164
Redemption of membership units at RTO, shares	6,671	413
Partners' Capital Account, Units, Sold in Private Placement	113	643
Stockholders' Equity, Other Shares	0	0

Shareholders' Equity and Non-_5

Shareholders' Equity and Non-Controlling Interests Class of Warrant or Right (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Feb. 10, 2020	Dec. 31, 2019	Dec. 31, 2018
Class of Warrant or Right [Line Items]
Class of Warrant or Right, Outstanding	8,125,000	2,259,000	6,085,000	2,040,000	2,259,000
Stock and warrants issued during period, shares		0
Warrants and Rights, expired	0	0

Shareholders' Equity and Non-_6

Shareholders' Equity and Non-Controlling Interests Warrants narrative (Details)	3 Months Ended
	Mar. 31, 2020$ / shares
Shares table narrative [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	30 days
Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term	10 years
Option Indexed to Issuer's Equity, Strike Price	$ 25
Warrant contractual weighted average life remaining	4 years

Shareholders' Equity and Non-_7

Shareholders' Equity and Non-Controlling Interests Noncontrolling Interest, Balance Sheet Allocation (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Subsidiary-specific information [Line Items]
Assets, Current	$ 68,122	$ 55,335
Assets, Noncurrent	465,607	636,342
Liabilities, Current	67,767	57,153
Liabilities, Noncurrent	130,791	139,730
Non-controlling interests	45,058	88,787
HSCP LLC [Member]
Subsidiary-specific information [Line Items]
Assets, Current	68,038	55,296
Assets, Noncurrent	452,280	584,812
Liabilities, Current	59,525	46,434
Liabilities, Noncurrent	91,035	75,219
Other Noncontrolling Interests	(491)	(1,041)
Accumulated equity-settled expenses	(148,310)	(111,934)
Net Assets	$ 220,957	$ 405,480
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	20.17%	21.64%
HSCP and USCo2 noncontrolling interests	$ 44,567	$ 87,746
Other Noncontrolling Interests	$ 491	$ 1,041

Shareholders' Equity and Non-_8

Shareholders' Equity and Non-Controlling Interests Noncontrolling Interest, P&L Allocation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Subsidiary-specific information [Line Items]
Net loss	$ (222,229)	$ (30,804)
Less: net loss attributable to non-controlling interests	(50,275)	(7,427)
HSCP LLC [Member]
Subsidiary-specific information [Line Items]
Net loss	$ (235,203)	$ (28,958)
Weighted average ownership percentage of convertible noncontrolling interests	21.15%	25.63%
HSCP net loss allocated to convertible NCI	$ (49,745)	$ (7,422)
HSCP net loss allocated to non-convertible NCI	$ (530)	$ (5)

Shareholders' Equity and Non-_9

Shareholders' Equity and Non-Controlling Interests NCI Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Class of Stock [Line Items]
USCo2 Ownership of HSCP	0.61%
USCo2 Voting Shares held by Pubco	69.00%
USCo2 non-voting shares	31.00%
HSCP ownership by LLC members	19.56%
HSCP owned by Pubco	79.83%
NCI adjustments for changes in ownership, value	$ 0	$ 0
Noncontrolling Interest [Member]
Class of Stock [Line Items]
NCI adjustments for changes in ownership, value	$ 6,564	$ (3,640)

Shareholders' Equity and Non_10

Shareholders' Equity and Non-Controlling Interests Schedule of Conversions by Stock (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Jan. 01, 2019	Dec. 31, 2018
Shareholders' Equity and Non-Controlling Interests [Abstract]
Convertible NCI units outstanding	24,612	27,397	25,035	27,340
Issuance of NCI units	0	198
Canceled NCI units	(1,310)	(123)
Profits interests vested to NCI units	1,000	625
NCI units settled in cash	0	(643)
NCI units converted to Pubco shares	(113)	0

Equity-Based Compensation Expen

Equity-Based Compensation Expense by Plan (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense	$ 34,737	$ 18,977
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum	15.00%
ACRG Omnibus Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense	$ 19,290	18,881
Other equity awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense	$ 15,447	$ 96

Equity-Based Compensation RSU (

Equity-Based Compensation RSU (Details) - USD ($)	Jun. 24, 2020	Mar. 13, 2020	Mar. 11, 2020	Feb. 20, 2020	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense					$ 14,888
Equity-based compensation expense					34,737,000	$ 18,977,000
Payment, Tax Withholding, Share-based Payment Arrangement					$ 0	$ 2,790,000
RSUs delivered in current period that vested in prior period						4,000
RSUs vested with delivery deferred					744,000
RSUs granted to executives resulting from CGC transaction					4,909,000
Vesting schedule for RSUs granted to executives resulting from CGC transaction					25% in June 2020, 25% in June 2021 and 50% three months following the Acquisition (as defined in Note 13)
RSUs granted to executives resulting from CGC transaction, expense					$ 2,762,000
RSUs granted to employees resulting from CGC transaction					1,778,000
RSUs granted to employees resulting from CGC transaction, expense					$ 2,049,000
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number					9,158,000		7,843,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value					$ 10.99		$ 15.10
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted		630		1,505	4,155,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 6.41	$ 2.15	$ 4.50	$ 5.11	$ 3.68
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period					(1,593,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value					$ 14.48
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period					(1,247,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value					$ 8
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period					2 years
Equity-based compensation expense					$ 13,414,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value					$ 3,503,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms					2 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding					$ 21,247,000
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount					$ 77,083,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition					2 years

Equity-Based Compensation Optio

Equity-Based Compensation Options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount	$ 41,088
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	5,067		5,607
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 21.71		$ 21.56
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	191
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 5.75
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares	(731)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price	$ 16.39
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	1,718
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 24.80
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	9 years
Equity-based compensation expense	$ 34,737	$ 18,977
Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense	$ 5,876
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	2 years

Equity-Based Compensation Profi

Equity-Based Compensation Profits Interests (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense	$ 34,737	$ 18,977
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense	$ 70
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	0		1,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 0		$ 0.43
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(1,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	$ 0.43
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$ 1,239

Equity-Based Compensation Restr

Equity-Based Compensation Restricted Shares (Details) - USD ($) $ / shares in Units, $ in Thousands	Jun. 24, 2020	Mar. 13, 2020	Mar. 11, 2020	Feb. 20, 2020	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Apr. 16, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense					$ 34,737	$ 18,977
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted		630		1,505	4,155,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 6.41	$ 2.15	$ 4.50	$ 5.11	$ 3.68
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount					$ 77,083
Equity-based compensation expense					$ 13,414
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number					9,158,000		7,843,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value					$ 10.99		$ 15.10
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period					2 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms					2 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding					$ 21,247
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition					2 years
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount					$ 1,991
Equity-based compensation expense					$ 15,377
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number					1,128			1,369
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value								$ 20.45
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period					24 months
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms					1 year
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding					$ 559
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition					1 year
Share-based Payment Arrangement, Tranche One [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted				148

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2018
Business Acquisition [Line Items]
Option premium, Per share	$ 2.63
Option premium, Value	$ 300,000
Share conversion, Per unit	0.5818
Shares authorized, Canopy Growth Transaction	58,000,000
Shares authorized, Canopy Growth Transaction, Remaining available	39,000,000
Indemnification Obligation, Surety bonds	$ 5,000
Consulting fees contingent on services performed, Equity value	$ 8,750
Consulting fees contingent on services performed, Shares	400,000
Deep Roots - Pending [Member]
Business Acquisition [Line Items]
HSCP common units to be issued	4,762,000
Common units, Value, To be issued	$ 11,048
Share Price		$ 2.32
Cash payable upon closing	20,000
GCCC - Pending [Member]
Business Acquisition [Line Items]
Cash payable upon closing	$ 10,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Jun. 24, 2020	Mar. 13, 2020	Mar. 11, 2020	Feb. 20, 2020	Feb. 10, 2020	Mar. 31, 2020	Mar. 06, 2020	Jan. 01, 2020	Dec. 31, 2019	Mar. 31, 2019
Related Party Transaction [Line Items]
Convertible Debt			$ 22,000		$ 27,887	$ 18,800,000	$ 18,800,000			$ 0
RTO expense settled in shares			41		1	1
SVS secured for loan						12,000
Related Party Debt			$ 21,000			$ 0		$ 5,000	$ 15,000,000
Restricted Stock Units (RSUs) [Member]
Related Party Transaction [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 6.41	$ 2.15	$ 4.50	$ 5.11		$ 3.68

Income Taxes Income Tax Provisi

Income Taxes Income Tax Provision (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Taxes [Abstract]
Income Tax Expense (Benefit)	$ (28,572)	$ 2,222

Income Taxes Rate Reconciliatio

Income Taxes Rate Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Rate Reconciliation [Abstract]
Income Tax Expense (Benefit)	$ (28,572)	$ 2,222

Reportable Segments (Details)

Reportable Segments (Details)	3 Months Ended
	Mar. 31, 2020
Reportable Segments [Abstract]
Number of Reportable Segments	1

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Jun. 16, 2020	May 29, 2020	May 28, 2020	May 08, 2020	Mar. 31, 2020	Mar. 11, 2020	Mar. 06, 2020	Feb. 10, 2020	Mar. 31, 2019
Subsequent Event [Line Items]
Convertible Debt					$ 18,800,000	$ 22,000	$ 18,800,000	$ 27,887	$ 0
Subsequent Event
Subsequent Event [Line Items]
Proceeds from sale of investment				$ 1,000
Convertible Debt		$ 11,000	$ 50,000
SVS issued for consulting, value			$ 50,000
Debt Instrument, Redemption Price, Percentage		95.00%	95.00%
Proceeds from Issuance of Debt	$ 15,000	$ 10,000
Debt Instrument, Interest Rate, Stated Percentage	60.00%	15.00%
Debt Related Commitment Fees and Debt Issuance Costs	$ 943
Debt Instrument, Convertible, Conversion Price		$ 1.68
Debt Instrument, Debt Default, Description of Violation or Event of Default	$ 6,000
Debt Conversion, Name [Domain] | Subsequent Event
Subsequent Event [Line Items]
Convertible Debt		$ 550

Quarterly Financial Data (una_2

Quarterly Financial Data (unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Quarterly Financial Data (unaudited) [Abstract]
Total revenues, net	$ 24,225	$ 12,897
Gross Profit	9,954	5,320
Net loss	(222,229)	(30,804)
Net Income (Loss) Attributable to Parent	$ (171,954)	$ (23,377)
Net loss per share attributable to Acreage Holdings, Inc. - basic and diluted:	$ (1.85)	$ (0.29)

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net Income (Loss) Attributable to Parent	$ (171,954)	$ (23,377)
Net loss per share attributable to Acreage Holdings, Inc. - basic and diluted:	$ (1.85)	$ (0.29)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	46,962,000	37,588,000
Profits interests vested to NCI units	1,000,000	625,000
Weighted average shares outstanding - basic and diluted	92,902,000	79,440,000
Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities	$ 0	$ 0
Noncontrolling Interest [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	24,612,000	27,397
LLC Profits Interests [Member]
Profits interests vested to NCI units		1,200
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	8,125,000	2,259
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	5,067,000	4,902
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	9,158,000
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		1,830

Uncategorized Items - q12020for

Label	Element	Value
Class D Share - Canopy Reorganization	acrg_ClassDShareCanopyReorganization	12
Percent of Class D Share - Canopy Reorganization	acrg_PercentofClassDShareCanopyReorganization	0.300
Fixed Shares Percent - Canopy Reorganization	acrg_FixedSharesPercentCanopyReorganization	$ 0.3048
Plan of Reorganization, Amount of Prepetition Obligations to be Settled in Cash	us-gaap_PlanOfReorganizationAmountOfPrepetitionObligationsSettledOrToBeSettledInCashAtEffectiveDate	$ 37,500
Class E Share - Canopy Reorganization	acrg_ClassEShareCanopyReorganization	28
Percent of Class E Share - Canopy Reorganization	acrg_PercentofClassEShareCanopyReorganization	0.700